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Introduction 
The history of the Usher syndrome 
At the beginning of the 19th century people acknowledged that heanng impairment could be 
hereditary. Wilde, an otologist in Dublin, was one of the first to indicate inheritance as a 
cause of deafness ' On the basis of a census, during which he distributed a questionnaire 
among the deaf, he concluded. "The transmission of diseases by hereditary taint or family 
peculiarity is very manifested among the deaf and dumb. " 
During the 19th century many doctors conducted studies on heanng impaired and deaf 
populations. It was noted that heanng impairment frequently occurred in combination with 
other disorders, such as ophthalmological diseases, mental retardation, epilepsy and 
polydactily.2 3 These observations resulted in the first otological syndrome descriptions 
In the field of ophthalmology, attention was paid specifically to the combination of 
degenerative disorders of the retina and hearing impairment Alfred Graefe, a German 
ophthalmologist, was the first to wonder about the combination of retinitis pigmentosa and 
deafness after being consulted by a deaf patient with retinitis pigmentosa. This patient told 
him that two out of his four sibs were suffering from the same disorder. 
The famous ophthalmologist Albrecht von Graefe, uncle of Alfred Graefe, reported on this 
case in his scientific journal in 1858 " He added that it would have been interesting to know 
whether pigment disturbances found in the retina were also present in the acoustic nerve, 
thereby suggesting that these disorders might have a common etiology. He also mentioned 
that a hereditary trait seemed to be present in these cases. 
In 1861, another German ophthalmologist, Liebreich, conducted a detailed survey among 
the deaf inhabitants of Berlin.2 He focused on the occurrence of retinitis pigmentosa in the 
deaf and was struck by the high prevalence of retinitis pigmentosa in this population. He 
noted that members of affected families were either affected by the combination of retinitis 
pigmentosa and deafness, or remained free of symptoms. Both disorders seemed to be 
more prevalent in consanguineous families, which was the case in many Jewish families in 
Berlin After Liebreich, various authors reported on the occurrence of retinitis pigmentosa in 
combination with hearing impairment. 
Arthur Hartmann performed a study on heanng impairment in Germany in 1880.5 In a 
separate chapter he commented on the combination of visual impairment and deafness. He 
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emphasized the importance of educating the heanng impaired and promoted the oral 
method which, at that time, had not been accepted in Europe. In this context he also 
mentioned the difficulties involved with educating children who were heanng impaired as 
well as visually handicapped. 
De Wilde, one of the first doctors to wnte about this bi-sensonal handicap in the 
Netherlands, concluded that 22% (38) of 167 Dutch retinitis pigmentosa patients were also 
heanng impaired.6 Thirteen patients came from consanguineous families 
Other studies focused on the presumed common etiology of the disorders.78 Charles Lee, 
an London ophthalmologist ( 1883), suggested that a common developmental deficiency or 
error could be the basis of the retinal degeneration observed in children with a congenital 
heanng impairment.3 
Although several doctors had reported on this "syndrome" by the end of the century, the 
disorder was eventually named after the British ophthalmologist C H Usher. In 1916, he 
descnbed familial retinal pigment disorders and noted that 69 retinitis pigmentosa patients 
were also heanng impaired ' It is remarkable that he merely mentioned this fact and did not 
add any relevant information to the existing knowledge of the syndrome He presented 
several of these families in the 1935 Bowman lecture thereby shanng his knowledge with a 
large scientifically engaged public.10 This might have contnbuted to the fact that later on, his 
name became an eponym for this syndrome. Histoncally, it would have been more 
appropnate to name the syndrome after Alfred Graefe. 
In 1931, von Wibaut suggested an autosomal recessive mode of inheritance for the Usher 
syndrome " Although an X-lmked pattern had also been suggested, no substantial evidence 
is available nowadays.12 
In 1959, Hallgren estimated that the prevalence of the Usher syndrome was 3 per 100,000 
(0 3 %). I3 He based this estimation on data pertaining to the Swedish population and on 
figures from the literature. Presently, the prevalence of the Usher syndrome is estimated to 
be 3- 4 per 100,000. Among the congenrtally heanng impaired population the prevalence is 
thought to vary between 3- 5%, while amoung the population of blind people who are also 
congemtally heanng impaired, the prevalence can be as high as 50% H " 
It also became evident that the syndrome of Usher could manifest itself in different forms 
Julia Bell, one of the first leading, female geneticists ( 1922), noted that the degree of hearing 
impairment varied between the affected individuals.17 
Hallgren distinguished two clinical entities and proposed that two different genes were 
responsible for this The manifestation of psychiatnc disorders has been regarded as a 
separate type of Usher syndrome for some time and was referred to as the Hallgren 
syndrome. At this time, psychiatnc illnesses are no longer thought to be a clearly defined 
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subtype of the Usher syndrome. 
The syndrome of Usher appeared to be even more clinically heterogenous than was 
suggested by Bell and Hallgren. Vanous descriptions of clinical types have followed resulting 
in the original classification of Davenport and Omenn in 1977 (table I ) ι β 
Table 1 
Clinical 
the syndrome of 
Usher (latest 
modifications in 
italic face) 
Usher type 1 
Usher type II 
Usher type III 
heanng 
impairment 
congenital, 
severe to profound 
congenital, mild/moderate 
can be progressive 
congenital, 
progressive 
visual 
impairment 
RP starts before puberty 
RP starts 
before/after puberty 
RP starts 
before/after puberty 
vestibular 
function 
areflexia 
vanable 
normal 
variable 
Clinical Features 
Table I dates from the time before gene-linkage analysis These days classifications tend to 
be based on genetic subtypes Now that it is possible to determine genetic subtypes, 
attention should be focused on precisely describing the accompanying clinical features and 
redefining the ongmal classifications. 
Heanng impairment 
Usher type I has been characterized by severe to profound, congenital heanng impairment 
Speech and language development are hampered by this and most children attend special 
educational institutes for this reason. Today there are several institutes in the Netherlands 
specialised in educating people who are profoundly heanng impaired or deaf The first Dutch 
school for the deaf was founded by vicar Daniel Henn Guyot in Groningen in 1790. Guyot 
was inspired by the Frenchman De l'Epée who had been teaching the heanng impaired since 
1760 using a kind of sign language and the hand alphabet of Bonet (Figure I ) In 1828, Sir 
Martinus van Beek started educating four deaf pupils at his school in Gemert using a Dutch 
version of De l'Epée's sign language. In 1830 this Institute for the Deaf in Gemert was 
officially recognized. The present Institute for the Deaf in St Michielsgestel was founded in 
1840 under the supervision of the Bishops of Den Bosch and Breda. Martinus van Beek and 
his 46 pupils moved from Gemert to the Institute in St. Michielsgestel In Germany, 
education for the deaf focused on the oral method. Under this German influence the 
Rotterdam School for the Deaf opened in 1888 The oral method was promoted and the 
use of sign language was abolished at the several schools for the deaf. Two more schools in 
favour of the oral methods were founded in the 19th and at the beginning of the 20th 
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century In the middle of this century, sign language was no longer officially taught at school 
The deaf nevertheless used their own sign language when communicating with each other 
The great revolution came in 1960 when William Stokoe proved that American sign 
language met all the cntena of a formal language and should be regarded as the mother 
tongue of the deaf From then on sign language has slowly been reintroduced at schools for 
the deaf Today, profoundly heanng impaired children are regarded to benefit most from 
sign language in combination with finger spelling, speech, reading and wntmg (Total 
Communication) " Most Usher type I patients use total communication, but face dramatic 
problems when their visual fields and visual acuity detenorate Using sign language becomes 
more difficult and communication may be reduced to finger spelling in the hand 
Figure I 
The hand 
alphabet by 
Bonet(l620) 
«^ 'I®»!**) 
?^LÄJ 
People with the Usher syndrome type II are less handicapped by their hearing impairment 
than Usher type I patients, because they are mildly to moderately hearing impaired Their 
heanng loss is most marked in the high frequencies and might benefit from hearing aids 
Van Aarem et al proved that heanng impairment in Usher type II can be stable as well as 
progressive 20 It is not known whether hearing impairment in Usher type I and Usher type II 
show any overlap 
Usher type III, mainly reported in Finland, is charactensed by progressive heanng loss 
Heanng can be nearly normal at birth but detenorates over the yeare2I 
Vestibular impairment 
The typical feature of Usher type I is vestibular areflexia, which has been found in most 
patients Owing to areflexia of the vestibular organ, delayed motor development is often 
seen in Usher type I children In general, they do not start walking until the age of 18 months 
or older Learning to ride a bicycle can cause problems for the same reason Recently 
Otterstedde et al reported of Usher patients who had been profoundly hearing impaired 
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since birth and therefore classified as Usher type I They were found to have a normal 
vestibular function." 
Vestibular reactions could be elicited in Usher type II patients, who generally did not have a 
history of vestibular problems 
In Usher type III, vanable vestibular reactions are reported, ranging from areflexia to 
hyperreactivity.23 
Visual impairment 
Retinitis pigmentosa is regarded to have a congenital ongm, but clinical symptoms are not 
usually found until an older age Night blindness, caused by decreased sensitivity of the 
photoreceptor cells, is one of the first clinical symptoms. In Usher type I, onset of night 
blindness is reported at the age of 5 years. 
Night blindness in Usher type II occurs several years later. Night blindness is followed by 
constnction of the visual fields, caused by degeneration of the penpheral photoreceptor cells 
Visual acuity may remain intact for many years, but can be disturbed by cataract formation. 
Fundoscopy of the tapetoretinal degeneration shows bone spicules in the penpheral to mid-
penpheral retina, with central narrowing of the arterioles and a waxy optic disc. This typical 
fundoscopic picture may be absent in young children. 
On the other hand, subnormal electro-retmography (ERG) values may already indicate 
retinal pigment degeneration at an early age 24 
Gene identification and mutation screening 
Gene-linkage studies on the Usher syndrome, which started in the mid 1980s, are based on 
the clinical classification by Davenport and Omenn.16 
Usher type I families have been linked to 14q32 (USH I A).25 It soon became evident that not 
all type I families are linked to chromosome 14q32 USH IA seemed to be restncted to 
families who ongmated from the Pomtou-Charentes region in France. Most families with 
Usher type I have been linked to chromosome I I q 13.5 (USH IB).26 USH IC ( I I q 15 I ) has 
been encountered in another migrated, French population living in St. Louisiana (USA) 27At 
least 6 genetic subtypes are kown to be responsible for Usher syndrome type I.28 30 
Families clinically classified as Usher type II have been linked to chromosome I q 14 
(USH2A).29 Usher type II has also been linked to chromosme 5q 14.3-21.3 (USH2B)32 
Usher type ΙΒ and Usher type 2A are the most common subtypes and account for 75-80 % 
of the Usher syndrome 
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Table 2 
Genetic 
subtypes of the 
syndrome 
ofUsher 
Usher type 1 
Usher type II 
Usher type III 
genetic 
subtype 
USHIA 
USH IB 
USHIC 
USH ID 
USH IE 
USH IF 
USH2A 
USH2B 
USH3 
chromosomal 
location 
I4q32 
l l q l 3 5(MY07A) 
l lp IS 1 
lOq 
2lq 
lOq 
Iq4l (USH2Agene) 
5 q l 4 3 - 2 l 3 
3q2l-25 
author 
Kaplan et al, 1992" 
Weiletal, 1995 M 
Smith et al., 1992 27 
Wayne et al, 1996 2Θ 
Chaibetal, 1997 29 
Wayne et al, I997 3 0 
Eudyetal, 1998 * 
Pieke-Dahletal, I99832 
Sankilaetal, 1995" 
The mouse sh-1 gene was considered to be a candidate gene for USH IB, because the 
shaker-1 homozygous mouse is charactenzed by heanng loss and vertigo resulting from 
cochlear and vestibular neuroepithelial defects The sh-1 gene maps to a region of mouse 
chromosome 7 which is homologous to the USH IΒ region of the human chromosome 
I Iql3. 
A competitive search between genetic laboratones in Pans and Omaha resulted in the 
identification of the USH IΒ gene by the French in March, 1995. They submitted their data 
on the USH IΒ gene just before the Amencans. The news on the USH IΒ gene was 
nevertheless released in a joint publication.34 
In humans, the mouse sh-1 gene appeared to be a gene encoding the protein myosin 7A 
(MY07A). Two different premature stop codons, a six-base-pair deletion and 2 different 
missense mutations were detected in 5 unrelated USH IΒ families. These mutations, which 
are located at the ammo-terminal end of the motor domain of the protein, are likely to result 
in the absence of a functional protein (Figure 3) 
USH ΙΒ appears as a pnmary cytoskeletal protein defect. It is remarkable that MY07A 
mutations in humans result in audiovestibular defects and in retinal degeneration whereas no 
retinal disease was found in the sh-1 mouse. It is possible that other myosins could 
compensate for the loss of myosin 7A, or that phenotypical variation is caused by the 
character of the mutation itself. The autosomal recessive type of heanng impairment 
DFNB2, which also maps to I I q 13, could be the human equivalent of the sh-1 mutants. 
Myosin 7A is known to play an active role as motor-molecule in the function of cilia and 
microvilli in the human body.35 Expenments on mouse, chicken and human embryos 
demonstrated expression of myosin during embryogenesis in cochlear-, vestibular 
neuroepithehum and in the connecting cilia of the photoreceptor cells and retinal pigment 
epithelium 36 39 Weil et al noted that myosin expression seemed to be concomitant with the 
morphogenesis of the microvilli and cilia in epithelial cells.36 She suggested that myosin 7A 
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might play a role in the function of the stereocilia, but may be involved in the morphogenesis 
of these structures as well. Mutations in the myosin gene may result in dysfunction and 
dysmorphogenesis of the stereocilia 
Figure 3 
Nucleotide and 
deduced ammo-
aod sequences 
of the 2 myosin 
7A exons of the 
human gene 
containing the 
mutations a 
Exon I b Exon 
3 The 
mutations are 
indicated above 
and below the 
normal 
sequences and 
the 6-bp 
deletion which 
was found in 2 
different families 
is underlined A 
silent 
polymorphism 
was detected in 
exon I at the 
third position (G 
-> A) and in 
exon 3 at 
position 83 (C 
->T)» 
I ACG TAT ACG GGCTCC ATC CTG GTG GCT GTG AAC CGC TAC CAG CTG CTC TC 
T Y T G S I L V A V N P Y Q L L S 
51 ATC TAC TCG CCA GAG CAC ATC CGC CAG TAT ACC AAC AAG AAG ATT GGGG 
I Y S P E H I R Q Y T N K K I G E 
101 AGATG CCC CCC CAC ATC TTT GCC ATT GCT GAC AAC TGC TAC TTC AAC ATG 
M P P H I F A I A D N C Y F N 
Τ 
ISI AAA CGC AAC AGC CGA GAC CAG TGC TGC ATC ATC AG 
K R N S R D Q C C I I S 
STOP 
TA 
CATTT GGGAAT GCC AAG ACC ATC CGCAAT GAC AAC TCA AGC CGT TTC GGA 
F G N A K T I R N D N S S R F G 
C H 
AAG TAC ATC GAC ATC CAC TTC AAC AAG CGGGGCGCC ATC GAG GGCGCGAA 
K Y I D I H F N K R G A I E G A K 
51 
101 GATT GAG & G TAC CTG CTG GAA AAG TCA CGT GTC TGT CGC CAG GCC CTG G 
I E Q Y L L E K S R V C R Q A L D 
STOP 
151 AT GAA AGG AAC TAC CAC GTG TTC 
E R Ν Y H V F 
Several Dutch and Belgian families participated in a study by Weston et al.'10 A panel of 189 
genetically independent Usher I cases were screened for the presence of mutations in the 
N-termmal coding portion of the motor domain of MY07A by hetereoduplex analysis of 14 
exons. Twenty-three mutations were found segregating with the disease in 20 families Of 
the 23 mutations, 13 were unique, and 2 of the 13 unique mutations (Arg212His and 
Arg212Cys) accounted for the greatest percentage of observed mutant alleles (8/23, 31 %) 
Six of the 13 mutations caused premature stop codons, 6 caused changes in the ammo acid 
sequence of the myosin 7A protein, and I resulted in a splicing defect ( Table 3). None of 
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Table 3 
Summary of 
mutations in 189 
Usher-type IB 
cases for 
MY07A exons 
I-I4«> 
the mutations reported here were observed in 96 unrelated control samples, although 
several polymorphisms were detected 
Patient status and 
codon change 
Heterozygotes 
Cys3 1 Stop 
75delG(FS) 
l20del(FS) 
Arg2l2His 
ArB2l2Cys 
Arg302His 
Glu3l4Stop 
Arg2l2His-Arg302His 
468+Gin 
Pro503Leu 
532delA(FS) 
Homozygotes. 
ArE2l2His-Arç302His 
Tyr333Stop 
Exon 
3 
4 
5 
7 
7 
9 
9 
7 and 9 
13 
13 
14 
7 and 9 
9 
Mutation 
TGC->TGA 
del GAC 
delCGÇCAG 
CGT-»CAT 
CGT-»TGI 
CGC^CAC 
GAG-»IAG 
See above 
insert GCA 
ccc->cic 
delCAC 
See above 
TAT^TAG 
Number of 
chromsomes 
2 
2 
2 
2 
Origin 
Sweden 
Holland 
Australia 
Holland 
USA 
USA 
Holland 
Belgium* 
Holland 
Sweden 
USA 
Holland 
USA 
USA 
USA 
Belgium* 
USA 
'Families were collected from the West- Flander region, a Dutch speaking part of Belgium 
Eudy et al have isolated the gene USHERIN, which is responsible for USH2A M This gene 
encodes a novel protein with extracellular matnx motifs. Two regions of the human retina 
are particularly neh in extracellular matnx proteins: Bruchs membrane and the 
interphotoreceptor matnx. The mterphotoreceptor matnx occupies the space between the 
photoreceptors and the retinal pigment epithelium n It seems to be of importance in the 
adhesion of the retina to the retinal pigment epithelium Furthermore it forms a domain 
around the photoreceptor cells, which is said to be vital for their function. As yet, it is unclear 
what effect the defective extracellular proteins will have on the level of the 
interphotoreceptor matnx. It is assumed that the function and structure of the 
interphotoreceptor matnx will be damaged. Disorders of the interphotoreceptor matrix 
might interfere with retinal adhesion and/or result in the release of lysosomal enzymes, both 
of which will disturb the photoreceptors and cause degeneration 
In this context it is of interest to mention that giant retinal tears have been reported in 
patients with the Usher syndrome type II.43 Only 6 cases of giant retinal tears in combination 
with retinitis pigmentosa have been reported in the literature. Five out of these 6 cases were 
diagnosed with Usher syndrome type II. 
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Table 4 
Genes causing 
heanng 
impairment '" 
Location 
Ip34 
Iq2l 
Iq4l 
2q35 
2q36-q37 
3pl4 l -p l23 
5q3l 
5q3l 
5q32-q33 1 
6q2l 3 
7pl5 
7q2l-q34 
8ql3 3 
I l p l 5 5 
Ilq22-q24 
I l q l 3 5 
I2ql3 I l - q l 3 2 
I3ql2 
I3q22 
I4ql2-ql3 
I7pl l 2 
20ql3 2-ql3 3 
2lq22 l-q22 2 
22ql3 
Xp l l 3 
Xq2l 1 
Xq22 
Xq22 
Gene 
GJB3, KCNQ4 
COLIIAI 
USH2A 
PAX3 
COL4A3, COL4A4 
MITF 
POU4F3 
HDIAI 
TCOFI 
COLIIA2 
DFNA5 
PDS 
EYAI 
KVLQTI 
TECTA 
MY07A 
COL2AI 
GJB2 (Cx 26) 
EDNRB 
GOCH 
MYOI5 
EDN3 
KCNEI 
SOX 10 
NORRIN 
POU3F4 
DDP 
COL4A5 
Locus name 
DFNA2 
Stickler III 
USH2A 
Waardenburg Syndrome type 1/ III 
Alport Syndrome 
Waardenburg Syndrome type II 
DFNAI5 
DFNAI 
Treacher Collins Syndrome 
Stickler II 
DFNA5 
DFNB4, Pendred Syndome 
Branchio-Oto-Renal Syndrome 
Jervell & Lange-Nielsen Syndrome 1 
DFNA8, DFNAI2, DFNB2I 
DFNAI l,DFNB2, USHIB 
Stickler 1 
DFNBI,DFNA3 
Waardenburg Syndrome type IV 
DFNA9 
DFNB3 
Waardenburg Syndrome type IV 
Jervell & Lange-Nielsen Syndrome II 
Waardenburg Syndrome type IV 
Nome Disease 
DFN3 
DFNI 
X-lmked Alport Syndrome 
The Usher syndrome as a genetic disease 
By the end of the 1980s a small international research project was initiated on hereditary 
hearing impairment by Boys Town National Research Hospital, Omaha, Nebraska On a 
European level there was interest in participating in a project on heanng impairment and 
genetics Several European and Amencan genetic laboratones and clinics have decided to 
closely cooperate in order to identify genes which cause hereditary heanng impairment The 
European Work Group on Genetics of Heanng Impairment was therefore founded in 1990 
with financial support of the Italian Company Amplifon This project is being pursued with a 
19 
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Biomed grant from the European Union 
In the past, attention has been focused on the clinically recognizable, syndromic types of 
genetic heanng impairment Stimulated by the European Work Group on Genetics of 
Heanng Impairment an international, systematic study on the non-syndromic autosomal 
dominant-, and recessive types of heanng impairment has only recently been started The 
workgroup is distinguishing between syndromic and non-syndromic types There are 9 
syndromic types of heanng impairment, excluding the mrtochondnal syndromes, for which 
genes have been identified Twenty-one non-syndromic, autosomal dominant types 
(DFNA1-21), 25 non-syndromic, autosomal recessive types (DFNBI -25) and 7 non-
syndromic, X-lmked types (DFNI -7) have been reported 
In the context of gene-mapping studies on the Usher syndrome, it is important to be aware 
of new gene-linkage and gene-identification analyses on other syndromic as well as non-
syndromic types of genetic heanng impairment Thirty genes have been identified and it has 
been noted that one gene can be responsible for several types of heanng impairment (Table 
4)M Mutations of MY07A can be responsible for an autosomal dominant-, (DFNA I I ) an 
autosomal recessive-, (DFNB2) as well as a syndromic type of heanng impairment (USH IB) 
Histopathology 
In 1880, Arthur Hartmann, an otologist in Berlin, emphasized the importance of 
histopathological examination of the temporal bones of patients with heanng impairment, 
"Bei jedem Taubstummen musste nach seinem Tode eine genaue Sektion vorgenommen 
werden und musste dem Sektionsergebnisse die bereits wahrend des Lebens bezüglich des 
Leidens constatierte Thatsachen und die Angaben der Angehongen über die Entstehung 
desselben beigefugt werden Auf diesem Wege ware es möglich, uns Aufklarung zu 
verschaffen über manche Fragen, die durch unsere bishengen Erfahrungen noch nicht 
erledigt sind "^ 
Under the inspired leadership of professor Harold Schuknecht, a unique collection of 
temporal bone histopathological matenal has been compiled since the middle of this century 
Despite this enormous source of information, many questions have remained unanswered 
with regard to the histopathology of the Usher syndrome 
Now that information is available concerning the initial genetic defect in vanous types of 
Usher syndrome, it is of importance to relate this information to existing reports on the 
histopathology of the temporal bone and retina in the Usher syndrome In this way, 
hopefully answers will be revealed about the pathology of the syndrome of Usher 
The histopathology of the temporal bone has been descnbed m seven cases with Usher 
syndrome ^ " Marked degeneration of the organ of Corti was seen as well as atrophy of the 
Introduction 
stna vasculans and a lack of spiral ganglion cells. 
There is only one case report on the histology of the retina in Usher syndrome in the 
literature. Hunter found that the inner segment of the photoreceptors were shorter than 
normal, the outer segments contained stacked discs and in some parts of the retina the 
retinal outer segments and connecting cilia were missing.5'' Sixty per cent of the 
photoreceptor axomones were found to be abnormal in an eye of a patient with Usher 
syndrome. 
This study 
Participating institutes. 
By the end of the 1980s, before the Nijmegen Usher project had started, collaboration was 
established between the Otorhmolaryngology Department Nijmegen and the Genetics 
Department of Boys Town National Research Hospital, Omaha, Nebraska. At that time, this 
Amencan department was one of the few institutes in the world focusing on the genetics of 
hearing impairment. Although from a "gene-linkage" point of view, studies on autosomal 
dominant types of hearing loss would probably have been more rewarding, both institutes 
were interested in the autosomal recessive syndrome of Usher. The impact of a bi-sensonal 
handicap played an important role in this decision. At present, this collaboration is being 
continued in The European Work Group on Genetics of Heanng Impairment with 
participation of France, Sweden, Italy, Denmark, Spam and Finland. 
Study population and methods 
People with Usher syndrome 2A had already participated in a study on the heterogeneity of 
the Usher syndrome.55 Some of these patients were recruited during routine visits to clinics 
(the Otorhmolaryngology Department and Ophthalmology Department, University Hospital 
Nijmegen and the Interumversity Ophthalmologic Institute, University of Amsterdam) or at 
schools and institutes for the heanng impaired or the deaf-blind. Other patients were 
informed about the project by patient platforms. 
To continue the project, now focusing on Usher syndrome type I, we could again turn to the 
above-mentioned institutes. The Institute for the Deaf, St Michielsgestel, The Institute for the 
Deaf-Blind: Kalorama, Beek-Ubbergen and the Belgian Institute Spermalie, Bruges, have 
cooperated closely in this part of the project. 
Families were invited for audiovestibular and ophthalmological examination at the University 
Hospital Nijmegen. Audiological examination consisted of otoscopy, pure tone audiometry 
and, in the case of Usher type II, speech audiometry, tympanometry, stapedial reflex 
measurements and brain stem audiometry. To test the vestibular organ of the participants, 
we used a rotary chair and electro-nystagmography. Ophthalmological examinations focused 
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on fundoscopy, visual acuity testing, Goldmann penmetry, electro-retmography (ERG) and 
electro-oculography (EOG). 
Gene- linkage studies on the Usher syndrome were performed at the Boys Town National 
Research Hospital. Patients were mfomned about this collaboration and were asked to 
donate blood samples for linkage studies Families with more than one affected person or 
families with consangumuity were most informative in the gene-linkage analysis In the early 
stage of this project, only these families were included. 
Aims of this study. 
At the beginning of this study emphasis was on the Usher syndrome type I because a 
previous study already concentrated on Usher syndrome type II. Attention was focused on 
identification of earners of the Usher syndrome, descnbmgthe histopathology of the 
temporal bones in Usher type I and on stimulating gene-linkage and gene-isolation studies 
When the project proceeded, genes of the two most common genetic subtypes of the 
Usher syndrome; USHΙΒ and USH2A, were identified. We were able to redefine the 
clinical descnption of the genetic subtype USH IB. The clinical borders of this subtype were 
determined by companng it to the clinical picture of the genetic subtype USH2A. 
In this study we focused on the following aims, 
I Identification of obligate earners of Usher syndrome type I Information about carnership 
would be of help in genetic counselling, until the genes responsible for the Usher syndrome 
have been identified 
II Stimulate gene-linkage, gene-identification and mutation screening in Usher syndrome type I 
in particular and in the Usher syndrome in general List mutations which are common in the 
Netherlands with the intention of using mutation screening for the early diagnosis of the 
Usher syndrome. 
III Descnbe the histology of the temporal bone of Usher type I, with the intention of relating 
the clinical symptoms to the observed histopathology. 
IV Descnbe the clinical features of the two most common genetic subtypes. USH IΒ and 
USH2A, in order to explain the clinical differences on the basis of differences in gene defects 
Structure of this study 
Results of this study are represented in 4 successive chapters Each chapter will focus on its 
own specific topic 
Chapter2 presents the audiological and ophthalmological findings in obligate carriers of 
Usher syndrome type I 
Chapter Jdescnbes the histology of the temporal bones in two Usher type I patients 
Besides the histopathology of the inner ear, a morphometnc analysis is made of the cochlear 
nuclei in Usher type I. 
Chapter 4 reports on the audiological and ophthalmological findings in Usher type IΒ and 
Usher type 2A patients 
In Chapters, a summary of this study is given as well as the resulting conclusions 
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Clinical findings in obligate carriers of type I Usher syndrome 
M Wagenaar, Β ter Rahé, A van Aarem, Ρ L M Huygen, R Admiraal, E M. Bleeker-Wagemakers, 
AJLG Pmckers, WJ Kimberimg, C W RJ Cremers 
Abstract 
Seventeen obligate earners from 9 families with autosomal recessive Usher syndrome type I 
underwent otological, audiological, vestibular and ophthalmological examination in order to 
clinically identify possible manifestations of heterozygosity. Gene linkage studies were 
performed and 6 families showed linkage to chromosome I I q 13 5 while 3 families have so 
far failed to show linkage to the candidate regions Eight obligate earners had an abnormal 
pure-tone audiogram Two different audiometnc patterns could be distinguished when 
hearing loss was corrected for age and sex. Four earners (24%) had significant sensorineural 
hearing loss (SNHL) which increased at higher frequencies. The other 13 carriers had SNHL 
of about 10 dB at 0 25 and 0.5 kHz, but less at higher frequencies. Vestibular findings were 
generally normal Electro-oculography revealed a significant lower mean light peak/dark 
trough ratio in Usher type I earners compared to normal controls. The methods used in this 
study were found to be not specific enough to clinically identify earners of the Usher type I 
syndrome. It is nevertheless remarkable that a number of obligate camere showed significant 
audiological and ophthalmological abnormalities. 
Introduction 
Usher syndrome is an autosomal recessive form of retinitis pigmentosa (RP) and congenital 
heanng impairment The association of deafness and RP was first desenbed by Von Graefe 
( 1858) ' The syndrome was named after Usher who had emphasized its hereditary nature.2 
The prevalence of Usher syndrome in the general population is estimated at 3-4/100,000, 
the earner incidence is approximately l/IOO.3 5 
Usher syndrome was first classified into two clinical types and later into four clinical types. 
The existence of type IV is no longer tenable (Table I ). 
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Based on gene linkage analysis, type II has been divided into USH2A, which is linked to 
chromosome I q41, and USH2B which has not shown any linkage so far6 β Type I has been 
subdivided into USHIA which is linked to chromosome 14q32, USHIΒ linked to 
chromosome I I q 13 5 and USH IC linked to chromosome 11 ρ 13-15 " ' About 75% 
percent of the Usher type I patients are typed as IΒ l2 
Table 1 
Subtypes of the 
Usher 
syndrome heanng 
impairment 
Retinitis 
Pigmentosa 
vestibular function 
linkage analysis 
Usher type 1 
congenital, severe to 
profound 
prepubertal onset 
areflexie 
USHIA I4q32 
USHIB I l q l 3 5 
USHIC I l p l 3 - I 5 
Usher type II 
congenital, mild to 
moderate 
postpubertal onset 
normal 
USH2A Iq4l 
USH2B unlinked 
Usher type III 
congenital, 
progressive 
vanable onset 
vanable 
USH3 3 
Although genetic identification of obligate earners of different types and subtypes of the 
Usher syndrome may be possible in the near future, the aim of this study was to detect 
clinical manifestatons of heterozygosity So far, no such manifestations have been found for 
any autosomal recessive type of congenital deafnessl3 In a previous study on earners of 
Usher type USH2A by our group some typical findings were noted, but they did not prove 
to be sufficiently specific to enable clinical identification of the earners M In this study we 
examined obligate earners of Usher syndrome type I in order to trace subclinical 
charactenstics of heterozygosity 
Families and methods 
In this study, the parents of 2 or more affected children were considered to be obligate 
earners of Usher syndrome type I The diagnosis was based on medical history, otoscopie, 
audiovestibular and ophthalmological examination and on gene linkage studies 
Seventeen earners entered the study Pure-tone audiograms were measured according to 
the ISO 8253-1 standard at 0 5, 1, 2, 4 and 8 kHz for air and bone conduction l5 The 
individual P50 threshold values for presbyacusis, corrected for age and sex, were calculated 
according the ISO 7029 method "Additional auditory tests included speech discnmmation 
tests, tympanograms, stapedial reflexes and brainstem auditory evoked potentials 
Electronystagmography was performed to record vestibular evoked eye movements, to test 
smooth pursuit eye movements and gaze positions and to elicit optokinetic nystagmus 
responses Calonc tests were performed according to previously described methods M All 
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17 earners underwent a complete ophthalmological examination, including corrected visual 
acuity measurement, slit lamp examination, ophthalmoscopy, visual field examination with 
Goldmann penmetry, using test targets I-1,1-4, III-4 and V-5, electroretinography (ERG) and 
electro-oculography (EOG).17 ιθ The earners were matched for sex and age with normal 
controls. The EOG light peak/dark trough ratio of the nght eye was calculated and compared 
to that of the controls Student's t-test was used with a one-tailed significance level (P= 
0 05). 
Results 
Figure I shows the pedigrees of all 9 families who participated in this study. 
Figure I 
Pedigrees of the 
families involved 
in this study 
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Consanguineous mating was reported in 3 families Genetic evaluation of 9 families 
confirmed linkage to chromosome I I q 13 5 in 6 families (families C, D, E, F, G, H) Three 
different heterozygous mutations, two missense and one base deletion, in the myosin VIIA 
gene on chromosome I I q were found in 3 families (C, D, E) Two mutations substituted a 
cysteine and histidine codon for the same arginine codon in exon three (families C, E) l 2 The 
other mutation was found in exon one and resulted in a deletion of a base with a frame shift 
in ammoacid sequence and premature termination of protein assembly (family D) Three 
families (A, B, I) have so far failed to show linkage to the candidate regions for Usher type I 
Medical histones of the obligate earners did not indicate any relevant ear disease, exposure 
to ototoxic drugs or heanng impairment Garners 1, 5 and 15 reported previous noise 
trauma Otoscopy did not show any relevant abnormalities Eight earners had abnormal pure-
tone audiograms The audiograms of earners 1,2, 13 and 15 showed a dip at 4 kHz, most 
likely due to acoustic trauma Significant sensonneural heanng loss (SNHL) defined as hearing 
loss m excess of P95 for presbyacusis, was found in earner 4, 5, 6 and 7 Statistics of the air 
conduction tresholds minus the P50 for presbyacusis were calculated for each ear and 
frequency (Table 2) 
There was no apparent dependence on frequency, the grand average excessive heanng loss 
was approximately 9 dB However, it seemed valid to distinguish between the cases with 
significant SNHL (4, 5, 6, 7) and the other cases Gamers 4, 5, 6, 7 showed increasing 
heanng loss in excess of the P95 at increasing frequencies (mean values 10, I I , 14,28,37 
and 41 dB, respectively) The other earners showed decreasing heanng loss in excess of the 
P50 at increasing frequencies (mean values 10,8,4, 1,7 and 0 dB) When the cases with 
noise trauma (average hearing loss in excess of P50 of 16 dB at 4 kHz) were excluded from 
this analysis, the mean hearing loss in excess of the P50 at 4 kHz is reduced from 7 dB to 3 
dB Other auditory test results were all within normal range 
32 
Clinical findings in obligate earners 
Table 2 
Statistics of 
hearing loss (air 
conduction 
threshold minus 
PSOfor 
presbyacusis in 
dBHL) 
n= 17 
AD 
mean 
SD 
AS 
mean 
SD 
0 25 kHz 
9 1 
6 8 
105 
55 
0 5 kHz 
II 4 
85 
58 
55 
1 kHz 
55 5 
8 5 
6 6 
106 
2 kHz 
69 
II 9 
8 7 
174 
4 kHz 
I I 8 
178 
17 1 
178 
8 kHz 
8 6 
20 7 
I I 0 
21 5 
There was no spontaneous or gaze-evoked nystagmus and ocular motor responses were 
normal Calonc responses were also normal in all of the earners, except for earners 4 and 
14, who both had a mild unilateral canal paresis 
All the earners had a corrected visual acuity within the normal range No signs of retinitis 
pigmentosa were detected dunng ophthalmoscopy Garner 12 was excluded from further 
ophtha!moscopical examination because of diabetic retinopathy which had been treated with 
laser therapy In 4 earners, capsular and/or nuclear cataracts were detected, but these were 
normal for age In 4 earners (2 6,10 and 15) the EOG light peak/dark trough ratio was < 
I 80 (P95 of normal) Compared to the normal controls, the light peak/dark trough ratio of 
the EOG was significantly lower in Usher type I earners (P < 0 025) (Table 3)'8 The ERG 
was within the normal range in all earners 
TableJ 
Statistics of the 
EOG light 
peak/dark 
trough ratio 
USHI 
Normal 
Ν 
16 
16 
mean age 
55 6 
54 5 
mean 
1 98 
2 27 
SD 
0 33 
0 40 
EOG 
Mm 
1 33 
1 63 
Lp/Dt ratio 
Max 
2 66 
3 05 
% abnormal 
25 
125 
Discussion 
The subjects examined in this study were earners of Usher syndrome type I When 
interpreting the results, it is important to bear in mind that different genetic subtypes of 
Usher type I syndrome were present in this earner population 
Four earners (earners 4, 5, 6 and 7) had significant SNHL and 13 earners did not After 
correction for the cases with noise trauma, the remaining 13 cases had a heanng loss in 
excess of the P50 of some 10 dB at 0 25 kHz and 0 5 kHz but lower values at higher 
frequencies We did not measure bone conduction thresholds systematically in this study, 
however, if we assume that there was an average conductive loss of 5 dB as the audiograms 
seemed to indicate then there would only be a treshold increase of approximately 5 dB at 
the lower frequencies This was found to be valid for all the earners except for those with 
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significant SNHL. Similar results have been descnbed in earners of Usher type 2A l4 In 4 
obligate earners (4, 5, 6 and 7) with significant SNHL, we found increasing tresholds at 
consecutive frequencies (of these earners, earner 4 failed to show linkage to chromosome 
I I q) An increasing treshold at higher frequencies has also been found in patients with the 
Usher syndrome. 
Ophthalmological manifestations of heterozygosity of the Usher syndrome have been 
reported previously. Kloepfer et al. reported RP in 13% of heterozygotes of the Usher 
syndrome " Holland et al. reexamined these patients and mentioned fundoscopic changes 
(gyrate atrophy) in 3 of 10 earners 2C In contrast with the studies referred to above, no 
fundus abnormalities were found in the study by Sondheimer et al on non-classified earners 
of the Usher syndrome or in a study by Van Aarem et al on type 2A earners 2I l4 We were 
also unable to demonstrate retinitis pigmentosa-specific changes in the earners of Usher type 
I. Subjective dark adaptation measurements have frequently been used in the past for earner 
detection, but the results were contradictory.2223 For this reason we chose more objective 
methods: EOG and ERG. De Haas et al. noticed that the incidence of abnormal EOG in his 
senes was too high and too constant to be accounted for by normal vanabihty " In other 
studies, abnormal EOGs were also found in a high proportion of earners. The mean EOG 
light peak/dark trough ratio in earners of Usher syndrome type I was significantly lower 
compared to that in normal controls. In earners of Usher syndrome type II, the difference in 
this ratio was even more significant (p< 0,0005) compared to normal controlsιβ 
Although the audiological and ophthalmological findings demonstrated abnormalities in Usher 
syndrome heterozygotes, these tests were not specific enough to be used for individual 
earner identification. Therefore, gene linkage studies will be required to identify 
heterozygotes. 
It is nevertheless remarkable that significant abnormalities were found in earners. This once 
again raises the question as to whether Usher earners are more susceptable to noise trauma, 
viral infections, otological intoxication or degenerative processes.2526 Gene linkage and gene 
isolation may in due course provide more insight into the pathophysiology of these dual 
sensory impairments and may help to explain the phenomena found in earners of the Usher 
syndrome 
A detection method for heterozygotes of autosomal recessive genes might significantly 
increase the efficiency of genetic mapping efforts, because the small size of individual families 
severely limits the amount of data that can be obtained in genetic studies Our data suggest 
that it might be possible to obtain a modified estimate of the risk that a clinically unaffected 
person in an Usher family is a earner. Using Bayes theorem, this information may then be 
incorporated into a lod score calculation. It should be emphasized however that general 
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applicability of this approach requires information on a larger sample of obligate earners in 
order to assess the proportion of Usher heterozygotes that fall outside the normal range 
So far, information on heterozygotes in linkage calculations has improved the genetic 
mapping of several forms of X-lmked deafness, but it has not yet proved to be useful in 
studies on autosomal recessive forms of deafness27 29 The current results are nevertheless 
encouraging and express the need for further evaluation of this approach in genetic studies 
on the Usher syndrome and non-syndromal types of autosomal recessive childhood 
deafness 
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Carriers of the Usher syndrome type IB; is audiometrie identification 
possible ? 
M Wagenaar, A F M Snik, W J Kimberling, C R W J Cremers 
Abstract 
Some studies m the past have shown that earners of genes for recessive deafness can not be 
identified by standard audiometry. However, remarkable results with regard to the 
identification of heterozygotes have been reported using Békésy audiometry and Audioscan 
audiometry. In the present study, 9 obligate earners from 5 families with the Usher 
syndrome type IB were examined. Methods which reflect the function of the cochlea, 
including pure tone audiometry, Audioscan audiometry and otoacoustic emission 
measurements were used to detect (subtle) audiometnc manifestations of heterozygosity 
Abnormalities in hearing sensitivity were found in some obligate carriers but to the same 
extend in some of the controls. No statistically significant differences were found in the 
presence of audiometrie abnormalities between carriers and controls Additional audiologic 
measurements indicated that if heanng loss was present in Usher type IB carriers, it was 
presumably of cochlear ongin. 
It is concluded that carriers of the Usher syndrome type IB cannot be identified properly with 
standard audiometnc methods. 
Introduction 
The Usher syndrome is an autosomal recessive disorder with congenital sensorineural 
heanng loss and retinitis pigmentosa. It was discnbed by a Bntish ophthalmologist in 1914 
and affects approximately 3 to 4 per 100.000 people m todays world. Three different types 
of the Usher syndrome can be distinguished, based on the clinical features ' Gene analysis 
demonstrated that the clinical types I and II can be caused by genes on various loci (Table 
\).1Λ 
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Table 1 
Subtypes of the 
Usher 
syndrome 
Usher type 1 
heanng impairment congenital, 
severe to profound 
RP 
vest function 
linkage analysis 
prepubertal onset 
areflexie 
USHIA I4q32 
USHIB I l q l 3 5 
(MY07A) 
USHIC I l p l3 15 
Usher type II 
congenital, 
moderate stable or 
progressive 
postpubertal onset 
normal 
USH2A Iq l4 
USH2B unlinked 
Usher type III 
congenital, 
progressive 
vanable onset 
vanable 
USH3 3 
Information on the earner status might be of importance to members of a family with 
affected members As long as genetic identification of earners is not yet possible, there will be 
a search for tests that may identify clinically earners of the Usher syndrome 
Table 2 
Review of the 
literature on the 
audiometnc 
identification of 
earners of 
autosomal 
recessive 
heanng 
impairment 
year 
1957 
1966 
1968 
1971 
1989 
1991 
1992 
1995 
first author 
Wildervanck5 
Kloepfer' 
Anderson13 
Mc Leod10 
Marres7 
van Rijn8 
Meredrth1" 
van Aarem" 
autosomal recessive 
earners 
parents (n=30) 
parents/siblings USH 1 
(n=28) 
parents (n=60) 
parents/siblings USH II 
(n=8) 
parents (n= 10) 
parents (n=60) 
parents/siblings USH II 
(n=5) 
parents/siblings USH2A 
(n=IO) 
Audiometry 
type 
pure tone 
pure tone 
Békésy 
pure tone 
Békésy 
pure tone 
Békésy, 
Audioscan 
pure tone 
results 
normal hearing 
slight heanng loss 
notches (17%) 
high freq heanng loss 
normal heanng 
normal heanng 
notches (100%) 
heanng loss 
Throughout the years, several studies have focused on the identification of earners of 
autosomal recessive deafness using audiometnc tests. Table 2 summanzes the results of 
earner studies which have been performed in the past few decades Some studies found that 
an autosomal recessive gene did not have any influence on the heanng abilities of carriers 5 8 
Other authors, on other hand, desenbed heanng impairment in excess of the age-related 
heanng loss in the pure tone audiograms of earners of several autosomal recessive deafness 
syndromes912 
Anderson et al l3 and, more recently, Meredith et al '* reported typical heanng notches in the 
Békésy audiograms and/or the Audioscan audiograms of these earners These studies suggest 
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that more refined audiometnc methods might be able to trace some degree of heanng loss 
in earners In a comparative study, Meredith et al. found that Audioscan audiometry was 
more sensitive than Békésy audiometry to detect notches in heanng sensitivrty.14 Therefore, 
we focused on Audioscan audiometry and studied carriers of the Usher syndrome type IB as 
part of an ongoing project on the clinical and genetical aspects of the Usher syndrome type I 
As individuals with type I are more severely affected than individuals with the Usher 
syndrome type II we hypothesized that if an influence of the gene was to be measured in 
heterozygotes, it might be more prevalent in obligate carriers of the Usher syndrome type I 
than in carriers of the Usher syndrome type II. Therefore, we expected the audiometrie 
abnormalities found in the Usher syndrome type II earners to be even more pronounced in 
our study group of Usher type IB carriers In addition to Audioscan audiometry, otoacoustic 
emission measurements (OAE)15 were performed to verify the presence of heanng notches 
detected with Audioscan. 
The origin of possible (subtle) audiometrie abnormalities in the earners of the Usher 
syndrome type I may be related to the myosin Vila protein Recently the Usher IΒ gene has 
been identified as coding for this protein Myosin VI la may be important for the motion of the 
stereocilia in the inner ear but its exact function in the cochlea and retina is yet unknown 
Mutations in the gene may give nse to single ammo acid substitutions which would be 
expected to produce an abnormal myosin Vila while mutations which truncate the message 
would not be expected to produce protein product One would presume that in carriers 
with mutations that actually change the ammo acid composition, abnormal and normal 
myosin Vila protein would coexist in the cytostructure of the inner and outer haircells and 
audiologic charactenstics of the Usher syndrome, albeit mild, would be predicted In order 
to find audiologic evidence for the presumed cochlear origin of the heanng loss in the 
earners of the Usher syndrome type IB, if present, additional measurements (speech 
audiometry, auditory evoked potential measurements and stapedius reflex testing) were 
performed. 
Figure 1 
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Figure I shows the pedigrees of the families involved in this study. Garners are numbered I 
to 9. In 2 families the parents were related. Gene linkage data were available on all families, 
obtained from the Boys Town National Research Hospital (Omaha, Nebraska, USA). All 
pedigrees showed linkage to chromosome 11 q 13.5 and were therefore designated as 
USHIB. The obligate earners in this study, compnsmg 5 women and 4 men aged 40-75 
years, were the parents of one or more affected children. 
The diagnosis of the Usher syndrome type I in these children was confirmed by medical 
history and thorough otoscopical, audiovestibular and ophthalmological examination at the 
University Hospital Nijmegen (UHN).12 None of the earners complained of heanng 
impairment, except for earner #9, the oldest earner, who was using a heanng aid. A control 
group compnsmg 25 individuals ( 15 women and 10 men, aged 24-60 years) was recruited 
from the staff at the UHN. None of them had a history of heanng impairment. 
Pure tone audiometry was performed using the automated Hughson-Westlake procedure 
The Audioscan audiometer (Essilor, Ltd) with Beyer Dynamic DT48 headphones was used 
for this purpose, calibrated according the ISO 8253."The method of ISO 702917 was 
followed to calculate the P50 and P90 (50th and 90th percentile) threshold values for 
presbyacusis for each earner and control subject in relation to her or his age and sex. The 
thus obtained individual P50 and P90 values at 1,2,4 and 8 kHz will be compared to the 
measured values. This method has been described in more detail by Robbms and Sutton.18 
All the subjects were also tested audiometncally according to the Audioscan method M '9 2 0 
This method makes use of frequency sweeps at a fixed level (in dB HL) to scan heanng acuity 
from 0.25 to 8 kHz. The sweep rate was 15 s per octave. If the tone sweep was not heard 
in a certain frequency region, the intensity in that frequency region was increased 
automatically in 5 dB steps." Figure 2 shows a typical example of an Audioscan recording 
obtained from one of the earners. Notches in hearing sensitivity can be identified on these 
recordings. A heanng notch was defined as an increase in the heanng threshold of at least 15 
dB within one octave, with recovery at higher frequencies of at least 10 dB. We determined 
heanng notches in the frequency range of 0 5 to 3 kHz because notches in the 4 kHz range 
might result from noise exposure.1314 
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Figure 2. 
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Cochlear function was also evaluated by means of OAEs. Although OAEs and hearing acuity 
are related, this relation is not straightforward.15'21 Therefore, in the present study, OAEs 
were only used to verify audiometrically determined hearing notches. Transient evoked 
OAEs (TEOAE) were obtained with the IL088-system (Otodynamics, Ltd).15 Unfiltered 80 
ms clicks were used at a stimulus level of 80 dB SPL ( + / - 3 dB). The TEOAE plots were 
judged for the presence or absence of an OAE, based on the stimulus parameters, response 
parameters and spectra. 
In 5 out of the 9 carriers, who had (some) hearing loss, audiometrie evaluation was 
supplemented by speech audiometry, stapedius reflex measurements and brainstem 
audiometry (ABR) to study the site of the lesion. (The remaining 4 carriers were not included 
in this part of the study because hearing sensitivity was found to be normal.) 
Tests were performed in double-walled sound-treated rooms by the same person. Standard 
lists of monosyllables were used for speech audiometry. Stapedius reflex measurements with 
contralateral stimulation were carried out with a clinical acoustic impedance meter (Amplaid 
720). The test signals were pure tones of 0.5, 1, 2 and 4 kHz. In accordance with Anderson 
et al.13, stapedius reflex thresholds of 100 dB HL or more were considered to be 
pathological. For the ABR measurements, electrodes were placed on the forehead and both 
mastoids. The ground electrode was placed on the subject's wrist. Condensation and 
rarefaction clicks of 70 dB HL were applied, generated by the Medelec AS 10 with a duration 
of 0.1 ms and a repetition rate of 15 per second. If the response quality was poor, the 
measurement was repeated at 80 dB HL. Responses to 1024 stimuli, band pass filtered (0.1 -
3 kHz), were averaged and stored (Medelec ER94a). 
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Results 
Results of pure tone and Audioscan audiometry in obligate carriers are presented in Table 3. 
In 8 of the earners, the PTA was below 20 dB HL, which indicates normal heanng. 
However, earners #2, #4, #8 and #9 were found to have high-frequency sensorineural 
hearing loss (threshold at 4 and/or 8 kHz exceeding 20 dB HL). In carrier #8, the heanng 
loss was asymmetncal. In the control group, 24 out of the 25 subjects had normal heanng 
One subject had high frequency heanng loss. 
Next, the individual thresholds were compared to age and sex matched P50 values. This 
was done at 1, 2 and 8 kHz and the average differences were calculated (Table 3 rows 6 and 
7) The 4 kHz threshold was excluded to minimize the effect of noise induced heanng 
notches The average measured thresholds of the earners were 2.2 dB above the P50 values 
with a standard deviation of 9.0 dB. This difference is not statistically significant (t-test) (As a 
controle, we compared measured and P50 values of our control group; on average, a 
difference of 2 dB was found what was considered as adequate.) On an individual level, 44% 
of the earner's ears showed measured thresholds below the P50 values and 100% below 
P90 values. 
Table 3 
Results of pure 
tone audiometry 
andAudioscan 
audiometry in 
obligate earners 
of the Usher 
syndrome 
earner 
1 
2 
3 
4 
5 
6 
7 
θ 
9 
sex 
F 
M 
F 
M 
F 
F 
M 
F 
M 
age (y) 
40 
45 
51 
53 
59 
49 
53 
65 
75 
PTA 
0 5, 
AD 
12 
7 
10 
18 
8 
15 
8 
8 
25 
(dB HL) 
1, 2 kHz 
AS 
12 
3 
2 
13 
3 
5 
3 
18 
22 
threshold - P50 
1, 2, 8 kHz 
AD 
+ 2 
+ 3 
+5 
+3 
- 6 
+5 
- 2 
- 2 
+ 17 
AS 
+7 
+ 6 
-5 
- 2 
-16 
-2 
-9 
+20 
+ 15 
depth of notches 
(dB HL) 
AD AS 
15 15 
-
-
55 30 
-
-
-
-
-
AS, left ear, AD, right ear, - no notch in heanng sensitivity found 
The Audioscan method detected heanng notches in the 0.5 to 3 kHz range in 4 out of the 
18 ears (22%) of obligate earners (Table 3 rows 8 and 9). However, in 8 out of the 50 
control ears ( 16%) a heanng notch was also found. As the mean age in the control group (36 
years) was lower than that in the earner group (54 years) we re-evaluated these results using 
the data from subjects aged between 40 and 60 years in the earner group (n = 7; mean age 
51 years) and control group (n = 8, mean age 49 years). Table 4 summarizes the results, 
there were no statistically significant differences in the occurrence of notches between either 
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the whole earner and control groups or between the age-matched earner and control 
subgroups (x2- test, p > 0 05) 
Table 4 
Notches in g rouP ^ occurence of notches 
heanng earners 18 4 (22%) 
sensitive using
 c o n t r o | s 5 0 8 ( | 6 % ) 
Audioscan 
audiometry in carriers (40 - 60 y) 14 4(28%) 
obligate carriers controls (40 - 60 y) 16 4 (25%) 
and controls 
TEOAE measurements were introduced to verify the presence of audiometncally 
determined heanng notches. The spectra of the OAE of earners # I and # 4 , who had a 
heanng notch according to Audioscan audiometry, were examined. No reproducible 
response was found between 2 2 and 4 3 kHz in either ear of earner # I and between 2 3 
and 3 6 kHz in either ear of earner # 4 These results are in accordance with the notch 
region found by Audioscan audiometry. 
Next, a companson was made of the TEOAE response of the carriers with age between 40 
and 60 years and a control group of age-matched subjects with normal hearing taken from 
our database (unpublished observations) The result is presented m Table 5 Literature values 
on a population of subjects with normal hearing in the same age range have been added.21 
No statistically significant differences were found between the three groups. 
TableS study group ears TEOAE response (dB SPL)a 
TEOAE response 
, , present carriers 14 8 4 ± 2 9 
of earners and r 
controls within the present controls 34 9 0 ± 4 6 
same age range
 R o b i n e t t e2i 97 8 3 + 5 0 
a
 means ± SD 
participants were all 40-60 years of age Literature results are added (subjects with normal heanng 
and within the same age range) 
In earners # I and # 4 , who had a notch in heanng sensitivity, earners # 2 , # 8 and # 9 who 
had high-frequency hearing loss, additional audiometry was performed to venfy the origin of 
the hearing loss, or, more specifically, to see whether there were signs of retrocochlear 
involvement or middle ear problems Speech reception scores were evaluated in relation to 
the pure-tone thresholds, as desenbed by Gates et al.22 In all the earners tested, the speech 
reception scores were wrthm one standard deviation of the calculated values based on pure-
tone thresholds, which suggested that speech reception was in accordance with the level of 
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heanng loss without suspicion of neural involvement. Tympanometry showed normal middle 
ear pressure and compliance in all the 5 earners. 
The stapedius reflex was elicrtable at normal levels in 4 out of the 5 earners. In earner #9, 
no stapedius reflex could be elicited up to 120 dB HL. ABR showed reproducible responses 
with normal wave l-V intervals in all 5 earners tested. 
Discussion 
Pure-tone audiometry showed that most of the earners had heanng thresholds that were 
close to age-related normative values (see Table 3 rows 6,7). There was a tendency in the 
eldery earners (#8 and #9) to have heanng loss in excess of the P50. This seems to be in 
agreement with findings of other studies, which suggest that the cochlea of heterozygotes of 
the Usher syndrome might be more susceptable to degenerative processes or exogenous 
influences.9'" 
With use of Audioscan audiometry, heanng notches were detected in Usher type IB earners 
but the prevalence did not differ from that found in the control group. Hearing notches were 
found in 22% of the earners. A similar figure was reported by Anderson et al.13 who 
examined earners of autosomal recessive deafness using Békésy audiometry, whereas 
Meredith et al.14 found notches in 100% of the obligate earners of the Usher syndrome type 
II using the Audioscan method. Differences between the results of this study and the study 
performed by Meredith et al.H might be due to the fact that two populations with different 
diagnosis, viz. Usher type II and type I heterozygotes, were studied. The two types are 
genetical distinct and type I is more severe. We hypothesized that the influence of an Usher 
gene in earners of the Usher syndrome type IB would be more prominent than in earners of 
type II, but this did not seem to be the case. 
If we assume that the Usher gene affects cochlear function, then abnormalities are to be 
expected in tests that reflect the function of the cochlea but not in tests that reflect the retro-
cochlear or middle ear function, as was found in this study. The only exception was earner 
#9 in whom no stapedius reflex could be elicited. Nevertheless, retrocochlear involvement 
seems unlikely because of reproducible and normal ABR results. In their study, Anderson et 
al.13 also found abnormal stapedius reflex thresholds, even in the majority of their possible 
earners. They had no explanation for this observation and, in later studies, this finding could 
not be confirmed β " '2 Therefore, the absence of the stapedius reflex in carrier #9 remains 
unexplained 
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To conclude, notches in hearing sensitivity were not more common in the earners of the 
Usher syndrome type IB than in the control subjects If heanng loss was present, it was most 
probably of cochlear ongin 
Although the number of earners is limited, a clinically relevant conclusion can be drawn 
Carriers of the Usher syndrome type IB do not show charactenstic audiometnc 
abnormalities which would enable their identification by standard audiometnc testing 
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Histopathology of the temporal bone in Usher syndrome type I 
M Wagenaar, H Schuknecht t, J NadolJr.MJL Benraad-van Rens, WJ Kimberlmg, 
CWRJ Cremers 
Abstract 
Temporal bones of two Usher type I patients were examined using light microscopy In both 
patients, histopathological examination of the cochlea was characterized by a degeneration of 
the organ of Corti that was marked in the basal turn, atrophy of the stria vasculares and a 
decrease of the spiral ganglion cells. The cochlear nerves appeared diminished in population 
The sensory epithelium of the saccular and utricular maculae of patient I was normal for age 
The left temporal bone of patient II, who is genotyped as USHID or USHIF, demonstrated 
the typical picture of severe cochleo-saccular degeneration. 
Electron microscopy of the nght temporal bone of this patient revealed multiple inclusions in 
saccule, stria vascularis and organ of Corti Degenerative changes were found in the spiral 
ganglion cells. 
A review of the literature is given Present cases and reviewed cases are re-interpreted in 
order to find an explanation for the observed differences in histology 
Introduction 
Usher syndrome is charactenzed as an autosomal recessive form of sensonneural hearing 
impairment and a retinitis pigmentosa. Three different types can be defined based on their 
clinical presentation ' In Usher type I heanng loss is profound, vestibular function extinct and 
retinitis pigmentosa starts before puberty. Patients with Usher type II have a moderate, stable 
or slowly progressive hearing loss which may result in a severe hearing loss.2 Vestibular 
function is intact and retinitis pigmentosa is generallly diagnosed around puberty. Usher type 
III is rare and charactenzed by a mild heanng loss which is clearly progressive over the years 
Vestibular function can vary and retinitis pigmentosa is as found in Usher type II Usher type 
III has mainly been diagnosed in Finland and has not been encountered in the Netherlands 
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The Usher type I can be further subdivided into 6 genetic types (USHI Α-F) whereas Usher 
type II has two genetic subtypes (USH2A-B).4 '3 Usher type III shows linkage to only one 
locus.14 Usher type ΙΒ and 2A are most frequently encountered 
There have been 9 articles in literature which dealt with the histopathology of the temporal 
bone m people with the Usher's syndrome since 1907 l 5 2 3 Vanous authors have reported 
on the same patientl6 '7 '9 " 2 0 2I In total the temporal bones of 7 persons have been 
described (table I). Four cases were classified as Usher type I, I case of Usher type II and 2 
cases of Usher type III were reported. 
In this study we examined the temporal bones of two Usher patients who were clinically 
diagnosed as Usher Type I. One patient was genetically evaluated. A review of the literature 
on this topic is given With the new insights on the clinical course of Usher syndrome we re­
interpreted the ongmal reported cases in order to find an explanation for the observed 
differences in the histology 
Patients and methods 
Patient I was an 82 years old female She had 4 sibs who also were born deaf and were 
visually impaired at an early age. The patient attended a school for the deaf until the age of 
16. She was legally blind at 35 years of age. The diagnosis of the Usher syndrome in this 
patient was made by an ophthalmologist in 1945 who descnbed a typical ophthalmoscopic 
picture of a tapetoretinal degeneration Dunng ophthalmologic examination at the University 
Hospital Nijmegen (UHN) in 1988 the patient could not perceive light and ophthalmoscopy 
was not possible because of bilateral cataract. Otoscopie examination at this hospital in 1980 
revealed no abnormalities. Heanng thresholds could not be measured dunng audiometry 
No vestibular testing was performed. 
The patient was admitted to v Kalorama', centre for the deaf and blind in Beek-Ubbergen 
when it opened in 1979 The patient lived at Kalorama until she died in February 1994 
because of a urosepsis and respiratoryfailure 
Patient //was a 64 years old male who had one sister who was also diagnosed with the 
Usher syndrome type I Both were said to be born deaf and attended an institute for the 
deaf. Tapetoretinal degeneration was confirmed by an ophthalmologist and the patient was 
legally blind at the age of 50. He first attended otorhmolaryngology clinic UHN in 1979 By 
that time, audiometry showed no detectable heanng thresholds. The patient lived at 
Kalorama from 1979 until he died October 1994 because of a cerebrovascular accident at 
the age of 64 Neuroanatomical examination revealed recent ischemic damage in the area of 
the left medial artery with no signs of herniation. 
A few months before his death the patient and his sister had donated blood for genetic 
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analysis. These samples were send to the Boys Town National Research Hospital 
Unfortunately it was not possible to obtain blood samples from other family members 
Methods 
Neutral formaldehyde ( 10%) was injected into the middle ears through the tympanic 
membrane approximately 60 mm after the patients died. The temporal bones were 
removed at the UHN 7 hours after patient I died and 10 hours after patient II died The left 
and the nght temporal bone of both patients were send to the Massachusetts Eye and Ear 
Infirmary for histological preparation and interpretation. The left and nght temporal bone of 
patient I and the left temporal bone of patient II have been prepared for light microscopic 
study utilizing the standard EDTA decalcification and celloidin embedding technique followed 
by senal sectioning and haematoxylm and eosm staining.24 The nght temporal bone of the 
second patient has underwent preparation for electron microscopic study 
Results 
Patient I 
- Histopathology. The left and the nght temporal bones are nearly identical and can 
therefore be descnbed together The bony and membranous labynnths appeared to be in an 
excellent state of histologic presentation and preparation The external auditory canals, 
tympanic membranes, middle ears, bony labynnths and mastoids appear normal in both 
temporal bones. The ossicles are intact. The round and oval window niches are normal 
The organs of Corti are totally degenerated except for mounds of undifferentiated cells at the 
extreme apices. The tectonal membrane is either missing or severely atrophied. Reissner's 
membranes are atrophied and in the right cochlea it is displaced toward the basilar 
membrane. The stnae vasculares show near total atrophy (Figure I ) A quantitative study of 
the left cochlea shows a total neuronal count of 6776 which is an 81 % loss compared to 
neonatal normal and a 64% loss when compared to age-matched controls (Figure 2). 
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The saccular and utricular maculae and the cnstae show thin sensory epithelia but appear to 
be normal for age. In the inferior part of the left utricular macula there is a small, focal, well 
circumscribed area of disruption of the sensory epithelium. The sensory epithelial layer is 
replaced by stroma-like tissue which protrudes to overlap the area of sensory epithelium 
anterior to it. There is a similar smaller anomaly on the right utricular macula. These 
alterations appear to be embryonic variform anomalies and not related to Usher's syndrome 
The tectorial membranes are normal. The cochlear aqueducts are blocked by fibrous tissue 
which is not abnormal in adult temporal bones. 
The vestibular nerve trunks and the cochlear nerve trunks have been avulsed from the 
internal auditory canal. The cochlear nerve and all branches of the vestibular nerve appear 
diminished in population within the cnbose areas. The facial nerve trunks appear normal. 
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The sensory bundles are well differentiated by stain and structural differentiation. The 
endolymphatic sacs are normal. 
Patient II 
- Histopathology. The tympanic membrane of the left temporal bone is intact but retracted 
and the anterior segment shows fibrous thickening. The long process of the incus shows a 
large central core of fibrous tissue obviously caused by inflammatory osseous resorption. 
There is no evidence of an active inflammatory reaction in either the tympanic membrane or 
ossicles. The mastoid is well pneumatized. The organ of Corti is severely degenerated in all 
tums. Both the inner and outer hair cells are totally missing. The organ of Corti consists of 
only a partially differentiated cell mass. Deiters' cells can be recognized in some areas. The 
pillar cells are totally missing in all turns. Hensen's cells present degenerative forms with 
poorly defined cell outlines and nuclei of irregular shapes. The tectorial membrane is either 
severely atrophic or missing entirely. Reissner's membrane has collapsed onto the 
degenerated stria and organ of Corti (Figure 3). 
Figure 3. 
The left cochlea 
of patient II; The 
organ of Corti is 
severely 
degenerated in 
all tums. The 
stria vasculares is 
severely 
disorganised, 
(onginal 
magnification χ 
110) 
ear
 :~tu' 1 * ^ ·• ""*- -
"v. ,···. 
The stria vasculares is severely disorganised. There are groups of undifferentiated cells in 
diminished numbers separated by empty spaces throughout which are numerous, small, 
homogeneous, basophilic masses and a few acidophilic globules. A quantitative analysis of the 
cochlea shows an overall loss of neurons of 7 2 % compared to age-matched controls (Figure 
4). The cochlear neurons that remain have lost their dendritic nerve fibres. The cochlear 
nerve appears 3 0 % diminished. 
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Figure 4. 
The pathological 
findings of the 
left cochlea of 
patient II. I HC; 
inner hair cells, 
OHC; outer 
hair cells, tect. 
memb.: tectorial 
membrane, stna 
vase; stna 
vasculares. 
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The saccular macula is severely degenerated. The saccular wall has collapsed onto remnants 
of the degenerated otolithic membrane. The hair cells of the sensory epithelium are totally 
missing (Figure 5). 
Figure 5. 
The left 
vestibule of 
patient II. The 
saccular macula 
is severely 
degenerated, 
(onginal 
magnification χ 
43) 
The inferior branch of the vestibular nerve, which receives its input from the saccule and the 
posterior canals shows signs of secondary degeneration and appears diminished in cell 
population. The utricular macula and the cristae appear histologically normal. The superior 
branch of the vestibular nerve stimulated by the macula of the utricle and the lateral and 
superior semicircular canal appears normal. 
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- Electron microscopy. Electron microscopy did show multiple inclusions within the saccule, 
including the saccular wall. Inclusions were also seen in the stria vasculares and the organ of 
Corti. Figure 6 shows two ganglion cells and part of a third. Within the cytoplasm of one of 
the spiral ganglion cells are prominent vacuoles and inclusions, which are highly suggestive of 
an ongoing degenerative process of the spiral ganglion cell during life. These findings are not 
routinely seen in normal cells. There is also abundent evidence of postmortem autolysis, 
which includes the empty appearing vacuolization of cells and the disruption of the limiting 
membrane. 
Figure 6. 
Electron 
microscopy of 
the temporal 
bone of patient 
II. Degenerative 
changes in the 
spiral ganglion 
cells. 
57 
Chapter 3 
- Genetic analysis DNA was available only from patient II and his affected sister. Mutation 
screening revealed that patient II was homozygous for a missense mutation (Y1719C) in 
exon 37 whereas his affected sister was heterozygous for this mutation. This specific 
mutation of myosin Vila has also been observed in a normal control panel and because both 
affected sibs from a consanguineous marnage have complete different genotypes at the 
USH IΒ locus, the observed mutation is believed to be non-pathologic. Haplotype analysis 
for patient II and his sister was done with at least two sets of flanking markers for all known 
Usher loo Data excluded linkage to all the following genes: USH3 on 3q21 -q25, USH IA on 
14q32, USH IC on Ι Ι ρ 15 I, USH2A on chromosome I q41 and USH2B on 5q 14 3-
921 J . 1 4 4 6 8 1 0 " However, this family was observed to be compatible for linkage to a set of 
I Oq markers known to bracket the USH ID and USH IF genes (Figure 7). The two affected 
individuals were homozygous for all of the marker alleles in the critical region Furthermore, 
they share identity for these genes These observations suggest that these two individuals are 
afflicted with either USH ID or USH IF. Unfortunately, there are no crossovers in this crrtical 
region that would allowed us to distinguish between USH ID and IF. This is not surpnsmg 
because the two loci are close to one another on chromosome IO.79 Because the family of 
patient II is linked to USH ID or USH IF, it represents the first Dutch example of the disorder 
in Europeans. Furthermore, patient II is a distinct vanety of Usher type I, in which cochleo-
saccular degeneraton is a remarkable feature.The more common Usher type IΒ is due to 
mutations in myosin 7A which cause a neuro-epithehal defect. 
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Interpretation of the literature 
There have been 9 articles in the literature describing the histopathology of the temporal 
bones in the Usher syndrome.15 23 As demonstrated in table I there are 4 cases which are 
classified as Usher type I. One case was said to be Usher type II and 2 cases were said to be 
Usher type III. Unfortunately, it is difficult to assign the clinical type of Usher to each reported 
case with certainty. A full ophthalmologic, audiometnc and vestibular examination of the 
heanng impaired individual was not always been done. On the basis of the reported histones 
and physical examinations and with the present knowledge of Usher's clinical course we 
would like to present an alternative review of the literature (table I see presumed types). 
In 1927 Nager desenbed 2 cases of Usher's syndrome type I and presented the 
histopathology of the temporal bones. " Surprisingly he mentioned that a vestibular function 
was present in the second case although reactions were weak. We are not aware of Usher 
type I patients who maintain their vestibular function. The second case therefore might be an 
Usher type II based on a functioning labynnth. 
The patient desenbed by Belai and Schmidt was diagnosed to have Usher type III.18 " Usher 
type III is charactensed by a progressive heanng loss.3 
59 
author 
Siebenmann, 
I90713 
Nager, mT* 
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age 
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histopathology 
organ of 
Corti 
D, m BT 
D, m BT 
D, m BT 
D, m BT 
D, m BT 
D, m BT 
D, m BT 
D, m BT 
D, m BT 
stna 
vasculares 
A 
An 
PAS + 
An 
A 
Ν 
A 
A 
A 
A 
of the cochlea 
spiral 
ganglion cells 
Dc 
A 
A 
Dc 
Dc 
Dc 
Dc 
Dc 
Dc 
cochlear 
nerve 
D 
? 
D 
? 
? 
D 
D 
D 
D 
histopathology of the vestibulum 
saccule utncule 
Ν 
Ν 
Ν 
Ν 
Ν 
Ν 
Ν 
Ν 
D 
D 
connective tissue 
bndges, PAS+ 
Ν 
Ν 
reduction 
sensory cells 
Ν 
Ν 
Ν 
Ν 
Ν 
canals 
Ν 
Ν 
Ν 
Ν 
Ν 
Ν 
Ν 
Ν 
Ν 
vestibular 
nerve 
Ν 
Ν 
Ν 
? 
? 
Ns.N, 
Ns.N, 
D 
N s . D , 
Table I Review of the literature 
D - degenerated, D, in BT - marked degeneration in basal turn, A - atrophied, An - anomaly, Ν - normal, Dc - decreased, ? - not mentioned, 
Xs. supenor vestibular nerve, X/ - infenor vestibular nerve 
Histopathology 
When looking at the patient audiograms we are of the opinion that no major progression 
was seen over 14 years. We think this person might have been a Usher type II patient. 
A study by van Aarem et al. demonstrated that heanng loss in Usher type II can be 
progressive and result in a profound heanng impairment in the older patient.2 Earlier van 
Aarem et al described the temporal bones of an Usher type I patient23 Audiologic 
examination of this 75- year old male demonstrated a serious down-sloping hearing loss in 
the left ear Only slight residual heanng was found in the right ear because of an additional 
otitis media chronica. The patient has had remarkable good speech which suggested that his 
heanng ability had been better in the past and had progressed over the years We therefore 
assume this man might have been an Usher type II patient. Usher type III is unlikely since up 
till now Usher type III has not been encountered in the Netherlands Unfortunately, we had 
no vestibular tests at our disposal 
Discussion 
Based on the interpretation of the reported Usher types as described in the previous section 
we will re-evaluate the accompanying histology (table I ) 
It is remarkable that the histopathology of the cochlea shows such a uniform picture no 
matter what type of Usher involved. If each Usher type is due to a different mechanism one 
would expect to see some significant differences in the cochlea but this is not the case. All 
authors have described a moderate to severe degeneration of the organ of Corti which is 
marked in the basal turn of the cochlea Changes in the stna vasculares ranged from 
undefined anomalies16 to hypoplasia15 or even atrophia.181922 23 Spiral ganglion cells were said 
to be atrophied16 or decreased in population.15 ιβ 23 The cochlear nerve also appeared 
diminished in population l 5 1 6 2 2 2 3 Data on the cochlear histology of the present cases show 
similarity to each other and are consistent with the above described changes. The 
commonalities observed suggest the possibility of some pathologic pathway in the cochlea 
that is common in all types of Usher syndrome despite the differences in genetic background 
The histopathology of the vestibular organ on the other hand demonstrates a more vanable 
picture In the case of Usher type II and type III a rather homogenous picture was seen and 
no major structural vestibular abnormalities seem to be found.16 ιβ 22 One might have 
expected these results based on the fact that Usher type II and III are charactensed by a 
functioning vestibulum ' Nevertheless, Belai and Schmidt did mention a reduction of sensory 
cells in the maculae and cnstae.ie " 
The vestibular data on Usher type I show a more heterogenous picture. Vestibular testing 
reveals an areflexia in Usher type I patients and one therefore might expect some form of 
pathology of the vestibular apparatus. In case of USHIB, which constitutes 70% -80% of 
Usher type I, defects are found in the gene encoding the human myosin 7A .'c This protein 
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is expressed in the human vestibular neuroeprthelia.25 This finding also supports the 
hypothesis that abnormalities are to be expected in the vestibule in Usher type I. 
Siebenmann descnbed an Usher type I patient with a vestibular areflexia and found evidence 
of degeneration of the epithelium of the nght and left utnculus and to a lesser extent of the 
nght sacculus.15 In this study severe degeneration of the macula of the sacculus was found in 
the Usher patient genotyped as USHI D/l F (patient II). Nager on the other hand reported 
no major signs of degeneration of the vestibular apparatus of an Usher type I patient except 
for bndges of connective tissue in the utncle." Pathology of the vestibulum was not seen 
either in patient I in the present study 
After re-evaluation of the literature on the temporal bone histology in Usher syndrome it is 
concluded that clear degeneration of the organ of Corti is found regardless the type of Usher 
syndrome involved. If signs of vestibular degeneration were to be found, this was more likely 
to be the case in a Usher type I patient In case of USH I D/l F a typical picture of cochleo-
saccular degeneration is found 
The vestibular histology of Usher type I seems to vary from normal to severe saccular 
degeneration (patient I and patient II in this study). The observed histologic differences may 
be related to differences in genetic subtypes or to different mutations within the same genetic 
subtype. Even similar gene mutations may lead to inter-individual histologic differences based 
on interaction with other genes and/or external influences In the near future, it will be 
possible to determine more genotypes of patients with Usher syndrome Histologic studies 
on genotyped temporal bones can than be performed This will reveal if differences in 
genotypes indeed lead to the differences in histology as observed. It remains of importance 
to continue studying the histology of temporal bones of Usher patients since this might 
provide more insights in different pathophysiologic processes which play a part in the vanous 
genetic subtypes of the syndrome of Usher. 
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The cochlear nuclei in two patients with Usher syndrome type I 
M Wagenaar, R Draaijer, H Meek, H J ten Donkelaar, Ρ Wesseling, WJ Kimberlmg, 
CWRJ Cremers 
Abstract 
Hypothesis- Does long-term sound depnvation lead to degeneration of the cochlear nuclei 
in two Usher type I patients. 
Methods- The cochlear nuclei of these patients were morphometncally analyzed and 
compared with two age-matched controls Routine autopsy of the brainstems was 
performed before the design of this study was known. During this procedure, the ventral 
cochlear nucleus (VCN) can easily be damaged Five partially damaged VCN could 
nevertheless be analyzed in this study, including the nght VCN of Usher patient I and both 
VCN of patient 2. Using 15 μιτι thick senal paraffin sections of the cochlear nuclear complex, 
estimations of the volume, the neuronal density, number of cells and mean cell diameter of 
the dorsal cochlear nucleus (DCN) and VCN were obtained 
Results- This study presents unique matenal of the cochlear nuclear complex in two patients 
with Usher syndrome type I. Data regarding volume and total cell number of the VCN are 
influenced by the abscence of a part of the VCN. Results suggest a decrease in the mean 
diameter of the cells of the VCN in Usher patients Other parameters of the VCN and 
DCN, however, showed no major differences between the Usher type I patients and the 
controls 
Conclusion- Only minor degenerative changes are apparent in the cochlear nuclei of two 
Usher type I patients, who were depnved of acoustic stimuli since birth. 
Introduction 
The Usher syndrome is known as an autosomal recessive disorder charactenzed by a 
congenital heanng impairment. As a result of retinitis pigmentosa, progressive visual 
impairment can be seen from the first decade on Based on the clinical picture three types 
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can be distinguished. A profound heanng loss and vestibular areflexia is found in Usher type I 
whereas in Usher type II the vestibular function is intact and heanng is moderately impaired 
but can be mildly progressive. Vestibular function in Usher type III vanes, heanng 
impairment is mild but progresses. 
Usher type I consists of 6 different genetic sutrtypes (USHI Α-F). Usher type II has 2 
genetic subtypes (USH2A-B) and Usher type III shows linkage to one locuslc Type IΒ 
and 2A are most frequently encountered. 
Histological examinations of the temporal bones of Usher I patients have demonstrated a 
II 20 
severe degeneration of the cochlea. Recent studies also support the suggestion that the 
initial defect which causes profound heanng loss in 70% of the Usher syndrome type I 
(USH IB) is located at the level of the cochlea.2' 
With the possibility of prostetic restoration of stimulation to the congenitally, profoundly 
heanng impaired Usher type I patients, the question of the effects of this early cochlear 
degeneration on the central auditory system seems to be clinically relevant. Siebenmann in 
1907, already spoke of atrophic or hypoplastic signs in the cochlear nuclei of an Usher 
patient. Clear alterations were found in the ventral cochlear nuclei (VCN) changing the size 
and contour of the nucleus. Nager reported atrophy of the primary cochlear nuclei m a 
patient with Usher syndrome type I. Cremers and Delleman, on the other hand, found 
ΙΘ 
that the cochlear nuclei of an Usher type I patient were normal 
Meanwhile, prosthetic restoration by means of cochlear implantation has been offered to 
Usher type I patients Knowing that some of them are succesfully been using their implant, 
we were interested in the preservation of the first part of the central auditory pathway after 
long-term sound depnvation. 
Routine autopsies of the brainstems were performed before this study was planned. 
Unfortunately, the VCN can easily be damaged dunng routine autopsies Three VCN were 
severely damaged and excluded from this study Five partially damaged VCN were used for 
further analysis All DCN were intact. Data with regard to the volume of the VCN and the 
total cell number of the VCN have to interpreted with caution because data are estimates 
This study, nevertheless, presents unique matenal of the cochlear nuclear complex in Usher 
syndrome type I. Data on the cell diameter and neuronal density of the VCN were not 
influenced by the abscence of a part of the VCN The DCN was present in all specimen and 
a quantative analysis could be performed 
Materials and methods 
Materials 
In this study we examined the brainstems of two Usher type I patients who granted their 
bodies for post-mortem histologic research related to the Usher syndrome Brainstems and 
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temporal bones were removed within 6 hours after their death. Brainstems of the age-
matched controls were available. 
Usher patient I is an 82- year old female. She had 4 sibs who were also prelingually deaf and 
who became visually impaired at an early age. At the age of 35 she was legally blind because 
of retinitis pigmentosa which was diagnosed by an ophthalmologist in 1945. Audiological 
examination at the Nijmegen otorhmolaryngology clinic in 1980 revealed no heanng 
thresholds. Vestibular tests were not performed. The patient was diagnosed with Usher type 
I based on the above mentioned clinical symptoms 
She died of respiratory failure and of urosepsis in 1994. A neuropathologic examination of 
the brain revealed mild symptoms of aging and two small old ischemic foci. The brainstem 
was preserved for further analysis 
Histological examination of the temporal bones of this patient showed degeneration of the 
cochlea, atrophy of the stria vasculares and a decrease in spiral ganglion cells Histological 
findings of the vestibule were normal for age.20 
The patient never participated in a gene linkage study. Because all affected sibs died it has not 
been possible to establish the genotype of this patient. 
Usher patient 2 \% a 65- year old male. He and his sister were diagnosed with the Usher 
syndrome type I. Retinitis pigmentosa was diagnosed by an ophthalmologist and the patient 
was legally blind by the age of 50. He first attended the Nijmegen otorhmolaryngology clinic 
in 1979. By that time audiometry showed non-detectable heanng thresholds. At the age of 
65, the patient died of a cerebrovascular incident. Neuropathologic examination of the brain 
revealed evidence of recent ischemic damage in the area of the left medial cerebral artery. 
There were no signs of herniation and the brainstem was macroscopically intact and 
preserved for further analysis. 
The patient as well as his sister had donated bloodsamples for gene-linkage analysis. Data 
excluded linkage to the following genes. USHIA on 14q32, USHIC on Ι Ι ρ 15.1, USHIE 
on 21 q21, USH2A on I q 14, USH2B on 5q 14 3-q21.3 and USH3 on 3q21 -q25. A non-
pathological mutation was found in the MYO VI IA gene (USH IB). The family showed 
linkage to I Oq markers for USH ID and USH IF. Distinction between USH ID and USH IF is 
not yet possible because these loci are close to one another on chromosome 10. 
A histopathological study of the temporal bone of this patient demonstrated the picture of a 
cochleo-saccular degeneration in USH I D/l F.20 
Brainstems of a 84- year old female who died as a result of a lung carcinoma and a 72- year 
old male who passed away as a result of cardiac failure, were obtained by routine autopsy 
and used as controls (controls I and 2, respectively). Neuropathologic examination of the 
control brainstems revealed no ischemic changes. Controls had not suffered from a neuro-
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logical deficit nor did they have a history of heanng impairment other than age-related 
heanng loss. 
Methods 
In the undissected brain, the cochlear nuclei are completely covered by the cerebellum. 
After removal of the cerebellar hemisphere and the flocculus, the DCN and the postenor 
part of the VCN are visible in the lateral recess of the fourth ventncle on the lateral surface of 
the mfenor cerebellar peduncle. Because of the far lateral position in the brainstem of the 
VCN in particular, this nucleus is easily removed with the cerebellum or at least will be 
damaged during routine autopsy. Especially the rostral part of the VCN appeared to be 
vulnerable. 
Routine autopsies of the brainstems were performed before the design of this study was 
made. Unfortunately, the VCN were damaged dunng routine autopsies as outlined above. 
Three out of 8 VCN were too severely damaged to be included in this study. Five partially 
damaged VCN could nevertheless be used for further analysis, including the nght side of the 
brainstem of the first Usher patient (unknown subtype), both sides of the brainstem of the 
second Usher patient (USHID/F) and the left sides of the brainstems of both controls. All 
DCN were intact and a quantative analysis was possible. 
After fixation of the dissected brainstems in 4% formaldehyde for at least one month, the 
part of the brainstem containing the cochlear nuclei underwent further preparation. These 
parts were embedded in paraffin and cut transversely (i.e. perpendicular to the longitudinal 
axis of the brainstem) into senal sections of 15 μηη using a Reichert- Jung 2050 microtome. 
Every IO*'"1 section was stained with cresyl-violet (NissI), and adjacent sections for Luxol fast 
blue and hematoxylm-eosm, respectively. For morphometry the NissI- stained sections ( 150 
μπι apart) were analyzed. 
The following parameters were determined: I. The total surface area of the VCN and DCN 
to estimate the volume of both nuclei; 2. The number of cells, the mean cell diameter and 
the elhpticity of the neurons in the VCN and DCN. 
I. Estimation of the volume of the VCN and DCN. 
In each NissI stained section the VCN and the DCN were delineated and the surface area of 
the nuclei in each section was determined using a Kontron Videoplan measunng system. 
From these measurements, the total surface area per nucleus in the sections analyzed 
(Aampie)was determined. The volume of each VCN and DCN was calculated using 
Cavahen's pnnciple which implies that the volume of a certain structure can reliably be 
23 24 
estimated on the basis of eight systematic randomly sampled sections or more. 
Consequently, the volume of each nucleus was calculated by multiplication of A ^ ^ with 
150, i.e. the distance between the sampled sections (V= AHmpte . 150). 
Since the VCN were not fully present in the senal sections the procedure descnbed above 
68 
resulted in the volume of only the sampled part of the VCN as present in the section series 
To obtain an estimate of their total volume, reconstructions of the VCN were made (Figure 
I ). Since the entrance of the cochlear nerve is highly constant, the number of sections 
apperently missing rostral to the entrance could be determined, and thereby a reasonable 
estimate of the VCN volume " " 
Figure I 
Reconstructions 
of the VCN and 
DCN of Usher 
type I patients 
and controls 
nVIII 
ι "I 
(M medial direction, L lateral direction, C caudal direction, R rostral direction ) 
2 Estimation of the number of cells in the VCN and DCN 
In the VCN, all nucleoli in the sections sampled were counted All VCN cells appear to have 
one clear nucleolus and under these conditions nucleolar counts yield the most reliable 
26 27 
estimations of neuronal numbers in thick paraffin sections. When dividing this value 
(Njampie) by AMmpte, the surface density (ΝΑ), i.e. the number of cells counted per surface area 
of the sections analyzed, was calculated (N A = N ^ ^ : A ^ ^ ) . 
The volume density (Nv), i.e. the number of cells per unit volume of the nucleus analyzed, 
was calculated by division of NA by the section thickness (t) of 15^m (N v = N A : t). 
For the DCN, cell counts had to be based on counts of neuronal profiles in stead of 
nucleolar or nuclear counts since neither nucleoli nor nuclei were unequivocally visible in the 
small flattened cells of the DCN Unfortunately, this is less precise and requires correction 
since cell bodies, in contrast to nucleoli, can be split by the microtome knife and thus divided 
over two sections and counted twice while small caps can be overlooked or may be lost 
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dunng sectioning Therefore, we used the following corrections to calculate Ν from Ν 
(see VCN) for the DCN 2' " " 
N v = N A / D + t - 2h 
in which Nv = the number of neurons per unit volume, NA = the number of neurons per unit of 
sample area, D = the mean neuronal diameter, t = section thickness (I5^m ) and h = the height 
of the smallest recognizable cap in the section analyzed 
To determine D and h, the following formulae were used 3031 
D = d [ ( Ι -4π) d / (t + d)] 
in which D = the mean neuronal diameter, d = the mean profile diameter as seen in the sampled 
sections, andt = the section thickness (I5/Um) 
h = R - V ( R2 -R,,2) 
in which R = the mean neuronal radius, and r0 = the radius of the smallest visible profile 
To calculate the mean neuronal diameter, about 100 cells per nucleus analyzed were 
sampled in a systematic random way and drawn using a drawing tube at a magnification of 
466x The drawings were analyzed using a Kontron Videoplan measunng system which 
calculates the maximum, the minimum and the average diameters of the sampled profiles 
(drnax· ^mm a n d d) fr"om which the mean neuronal diameter was calculated with the formula 
of Smolen et al3 0 The ellipticity indices ( E index) of the cells in each nucleus were calculated 
by dividing d m i n by d m a x The values measured allow for reliable estimation of the neuronal 
densities with the above mentioned formulae 30 
The number of cells per VCN and DCN analyzed was calculated by multiplication N v, ι e 
the volume of the neurons per unit with the volume (V) of each nucleus (N = N v V) 
Results 
The human cochlear nuclei are composed of a VCN and a DCN The DCN contains 
a large vanety of cell types, and is situated dorsolateral to the mfenor cerebellar peduncle 
The VCN contains many different cell types and has been divided into anteroventral, ventral 
cap and posteroventral subnuclei, which borders are not well defined, however Therefore, 
in the present study the VCN has been investigated as one nucleus The cochlear nerve 
enters the VCN on the ventrolateral side of the inferior cerebellar peduncle Upon entering 
the brainstem, pnmary auditory fibers bifurcate into equal-sized ascending and descending 
branches The ascending branches run to the rostral tip of the VCN, whereas the 
descending branches course through the ventral and posterior parts of the VCN to reach the 
DCN 
In figure I, reconstructions of the cochlear nuclei as present in the brainstem specimens 
analyzed are shown The site of entrance of the cochlear nerve is also indicated The 
percentage of the VCN present in the sections was estimated using the entrance of the 
cochlear nerve, which usually enters in the middle of the VCN, as a reference point Values 
obtained demonstrated that 75% of the VCN of Usher patient I was present and 60% of 
the nght VCN and 41 % of the left VCN of Usher patient 2 was present For controls, about 
96% and 77% of the VCN were present 
% 
VCN 
Control 1 77 
Control 2 96 
Usher 1 75 
Usher2r 60 
Usher 21 41 
A 
1 (mm2 
3 29 
4.46 
3 70 
2 69 
2 60 
L 
) (mm) 
1 97 
2 57 
1 82 
1 37 
1 67 
Vo 
(mm3) 
6 84 
I I 46 
6 73 
3 69 
4 34 
V 
(mm3 
8.4 
I I 9 
9 0 
6 2 
106 
N A 
) (/mm' 
57 7 
61 0 
96 9 
62 5 
72 3 
N v 
!) (/mm3) 
3,833 3 
4,066 7 
6,460.0 
4,1667 
4,820 0 
No 
24,839 8 
46,604.4 
43,375 8 
15,375 1 
20,918 8 
N1 0, 
32,259 
48,546 
57,968 
25,625 
51,022 
d 
Gum) 
20 8 
20 7 
17 1 
159 
17 1 
D 
GuM) 
24 1 
24 0 
20 1 
18 1 
196 
E 
inde 
χ 
061 
0 54 
0 66 
061 
0 65 
Table I 
Parameters of the VNC the minimal % of the VCN present, between brackets, the maximal % of 
the VCN present, the mean area (A) the mean length (L), the uncorrected volume (V0 ), the 
corrected volume (V), the number of 'neurons per mm* (NJ, the neuron density (N ), the 
calculated uncorrected number of neurons (NQ), the calculated corrected number of neurons (N J, 
the mean somaprofile diameter (d), the mean somadiameter (D) of the cells of the VCN, the 
elliptioty index (E index) 
VCN 
Table I shows the estimated percentage of the VCN which was present in the examined 
sections The measured mean area (A) and length (L) which are extrapolated to 100% VCN 
are shown per specimen The corrected volume (V) can be calculated. The volume of the 
VCN of the Usher patients is 9 0, 6.2 and 10.6 respectively, whereas in two control 
specimen the volume of the VCN was 8.4 and 11.9 mm3. The number of neurons per mm2 
(N^, the neuron density (Nv), the number of neurons in the part of the VCN present (N0) 
and the corrected number of neurons ( N J of the VCN are also listed in table I Neuron 
density ranged from 4,166.7 till 6,460/ mm3 in the Usher patients and was 3,833.3 and 
4,066.7/ mm in the controls. For control I the neuron density was estimated using three 
parameters: nucleoli, nuclear profiles and neuronal profiles. Neuron density of the VCN was 
3,833.3/mm3 when counting nucleoli, 2,817/mm3 when counting nuclear profiles and 
3,157 9/mm3 when counting neuronal profiles 
The total number of cells of the VCN in the Usher specimen ranged from 25,625 till 57,968. 
A marked mtra-mdividual (Usher case 2) as well as inter-individual vanation is seen. 
Table I also shows the mean cell diameter ( d, i.e the mean of the maximal and minimal 
profile diameter) and the mean diameter (D) of the cells of the VCN. In the Usher patients 
the mean cells diameter was 20 1, 18.1 and 19.6 μπι respectively, in the controls 24.1 and 
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24.0 μπι. A decrease in the mean diameter of the cells of the VCN in Usher type I was 
found. The mean ellipticity index shows similar results in Usher and the control nuclei. 
Control 1 
Control 2 
Usher 1 
Usher 2r 
Usher 21 
A 
(mm2] 
1.48 
1.2 
1 97 
2.23 
1 98 
L 
) (mm) 
1.82 
1.82 
0.92 
1.22 
1.37 
V 
(mm3 
2 69 
3.13 
1 81 
2 72 
2.71 
N A 
) (/mm2) 
139.3 
88.0 
I I 1.5 
95 3 
109 0 
Nv 
(/mm') 
5,988 8 
3,688.2 
4,372 5 
4,097 2 
4,934.4 
N„ 
16,109.9 
1 1,544.1 
7,914.2 
1 1,144 4 
13,372.2 
d 
17.4 
166 
179 
17.3 
15.7 
D 
ψτη) 
20.1 
19.0 
20.6 
199 
17.9 
E 
index 
0.41 
0.47 
0 49 
0 42 
0.42 
Table 2. 
Parameters of the DCN; the mean area (A), the mean length (L), the volume (V), the number of 
neurons per mnf (NJ, the neuron density (Nv), total number of neurons (N,J, the mean 
somaprofìle diameter (d), the mean somadiameter (D) of the cells of the DCN, the ellipticity index (E 
index). 
DCN 
Table 2 shows the above mentioned parameters for the DCN. No clear differences were 
found in the volume of the Usher nuclei ( 1.81 ; 2.72; 2.71 mm3) and the control nuclei (2 69; 
3.13 mm3). Inter-individual vanation was seen in the Usher patients. Other parameters did 
not demonstrate major differences either when companng the Usher specimen to the 
controls. Neuron density was 4,372.5, 4,097.2 and 4,934.4/mm in Usher patients and 
5,988.8 and 3,688.2/mm3 in controls. The total cell number of the DCN m the Usher 
patients was 7,914 uptill 13,372 whereas in the controls I 1,544 and 16,109 cells were 
found. The mean diameters of the cells in the DCN were 20.6, 19.9 and 17.9 μπι in Usher 
patients and 20.0 and 19.1 μπη in controls. 
Figure 2 shows histograms refernng to the most relevant parameters. The estimated volume 
of the VCN did not differ substantially from the estimated volume of the VCN in the 
controls. No differences were seen for the DCN (Figure 2a). Figure 2b illustrates that the 
neuron density of the VCN seems to be higher in the Usher type I patient. No major 
differences were seen between the second Usher patient and the controls. In figure 2c the 
total number of neurons is shown. Within the DCN a rather similar distribution is seen The 
total number of neurons of the VCN on the other hand shows a marked intra- and mter-
mdividual variation. The mean diameter of the cells in the VCN (Figure 2d) tend to be some 
20% smaller in the Usher patients. 
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Figure 2d 
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Discussion 
In the past various authors have reported histological changes in the cochlea of patients with 
11 19 
Usher syndrome. Histopathological findings of the cochlea in two patients with Usher 
sydnrome type I revealed degeneration of the cochlea, atrophy of the stna vasculares and a 
decrease in spiral ganglion cells. The cochlear nerve appeared diminished in population 20 
Gandolfi et al reported on a patient with Cockayne's syndrome and a sensorineural hearing 
loss M He postulated that atrophy of the acoustic nerve may be related to degeneration of 
the neural elements in the cochlea. Atrophy of the spiral ganglion and cochlear 
neuroeprthehum is thought to cause a pnmary anterograde transsynaptic degeneration of the 
VCN based on deafferentation. 
Studies on sound depnvation and the development of the auditory pathway have mainly 
been earned out in animal models. Webster and Webster described expenments done on 
mice who were depnved of their conductive heanng ability. A decrease in the size of the 
globular cells and of the cross sectional area of soma profiles of the VCN was found. No 
changes were detected in the DCN. It is important to keep in mind that these animals are 
genotypically normal and retain their bone conduction. Furthermore, in mice physiological 
maturation of heanng will not start until 6-9 days post-natally whereas in humans a hearing 
ability is already present in utero. Therefore, Doyle and Webster as well as Niparko and 
36 37 
Finger looked for a more suitable model m mammals. Doyle and Webster described the 
effects of sound depnvation in rhesus monkeys after a conductive heanng loss was created 
by sutunng the external ear canal. They found no discernable changes in the VCN and 
36 
DCN. Niparko and Finger looked for changes in the cochlear nuclei in the Dalmatian m 
order to find a model of congenital sensonneural hearing loss. They reported a decrease in 
the number of cells in the VCN which seemed progressive with age. Overall these studies 
imply that an effect of sound depnvation can be found in the VCN. The DCN probably is 
less sensitive to sound depnvation considenng its scant input from the eight nerve and 
inhibitory role in audition 
Gandolfi et al. reported on the human cochlear nuclei m a sensorineural hearing impaired 
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patient with Cockayne's syndrome. He found a reduction of the volume of the VCN as 
well as a reduction in cell number and mean diameter of the cells. He mentoned that these 
findings may result from progressive deafferentation of the VCN over time. Seldon and Clark 
reported on the human cochlear nuclei in 2 postlinguistically deaf patients, I congenitally deaf 
patient and 9 normal heanng controls3Θ They found that the average neuron size in the 
Nissl-stamed, frozen sections was smaller in the postlinguistically deaf patients than in the 
control group Differences were more marked in the VCN than in the DCN. Smallest 
neurons were found in the congenitally deaf patients Moore et al. concentrated on the 
39 
central auditory nucleus in humans with profound sensorineural hearing loss Two persons 
with Scheibe's degeneration were descnbed and severe reduction in cell size was found in 
the VCN. 
In the present study a tendency is seen toward smaller mean diameter of cells in the VCN m 
a patient with Usher type I (unkown subtype) and in a patient with USHID/F Estimates of 
the volume and the number of neurons of the VCN does not differ substantially from the 
two controls, neither does the neuron density. No signs of degeneration are seen in the 
DCN of the two patents with Usher syndrome type I. The patient descnbed by Gandolfi et 
al was not thought to be totally deaf.34 Findings of the VCN, nevertheless, included a 
decrease in volume as well as cell number and cell diameter It remains unclear why in two 
patients with Usher syndrome type I who have been profoudly heanng impaired since birth, 
only a reduction in cell diameter of the VCN is seen Possibly, input from intracentral 
afférents does play a more important role than suspected. 
It should again be emphasized that the results from the present study should be interpreted 
with caution First, due to the far lateral position in the brainstem of the VCN and its close 
relationship to the cerebellum (especially of the rostral part of the VCN), dunng autopsy and 
gross dissection a part of the VCN was removed with the cerebellum. Therefore, data 
regarding the volume and number of neurons of the VCN are estimates. Second, for the 
DCN cell counts had to be based on the counts of cell profiles instead of nucleolar or 
nuclear counts, since neither nucleoli nor nuclei were unequivocally visible in the small 
flattened cells of the DCN. We do realize that this counting method is less precise and 
requires correction for which Abercombie's formula was used. To illustrate the error 
introduced by counting cell profiles, the neuron density in the VCN was calculated for the 
three parameters mentioned in control I. Counting nucleoli the neuron density was 3, 
833 3/ mm , for nuclear profiles 2,817 /mm and for cell profiles 3,157.9 /mm Therefore 
the use of cell profiles as counting parameter introduces an error, i.e. an underestimation of 
some 20% compared to nucleolar counts. For the estimation of the mean diameter of the 
cells a systematic random sampling method has been used which reduces standard error 
With these precautions in mind, the results seem to be in accordance with data reported by 
Moore et al. and Seldon and Clark on profoundly heanng impaired and deaf patents.38 ^  A 
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comparison of the postlmgually deaf versus control patients by Seldon and Clark, showed 
that the two groups did not generally differ significantly. These findings are of importance 
now that prosthetic restoration of the deaf is possible. Especially for Usher type I patients, 
whose vision will deteriorate over the years, a cochlear implant may be a valuable aid 
Cochlear implantation of 4 Usher type I patients also indicated that the central auditory 
pathway is able to resume parts of its function The preoperative unaided Fletcher indices 
(mean heanng impairment at 0.5, 1.0 and 2.0 kHz) of these patients were all above I 10 dB 
With heanng aid the Fletcher indices of three of the Usher type I patients vaned from 70 dB 
in one patient to above I 10 dB in the other two patients The one year postoperative 
Fletcher indices with cochlear implant ranged from 36 dB till 55 dB. A recent study by Saeed 
et al also emphasized that cochlear implantation may play a major role in the rehabilitation of 
certain deaf-blind individuals.'" Saeed et al. comment that these patients may be amoung the 
most worthwhile to consider for implantation. 
The latter two studies clinically support the results found in two patients with Usher 
syndrome type I in the present study, the cochlear nuclei show no major signs of 
degeneration notwithstanding long-term sound depnvation 
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Hearing impairment related to age in Usher syndrome type ΙΒ and 2A ; 
heanng impairment in USH2A is progressive 
M Wagenaar, A van Aarem, Ρ L M Huygen, S Pieke-Dahl, W.J. Kimberlmg, C W R.J Cremers 
Abstract 
Objective- To evaluate heanng impaimnent in two common genetic subtypes of Usher 
syndrome; USHΙΒ and USH2A. 
Design- Cross-sectional analysis of heanng threshold related to age in patients with 
genotypes determined by linkage-, and mutation analysis. 
Setting- Otolaryngology department, university referral center. 
Patients- Nineteen patients with USH ΙΒ and 27 with USH2A were examined. All 
participants were living in the Netherlands and Belgium. 
Main outcome measure- Pure tone audiometry of the best ear at last visit. 
Results- The patients with USH IΒ had residual heanng without age dependence with 
minimum thresholds of 80, 95 and 120 dB at 0.25, 0.5 and I -2 kHz, respectively. Mean 
thresholds of patients with USH2A were about 45-55 dB better than these minimum values. 
Distinctive audiographic features of patients with USH2A were maximum heanng thresholds 
of 70, 80 and 100 dB at 0.25, 0 5 and I kHz, respectively, only at age younger than 40 
years Progression of heanng impairment in USH2A was 0.7 dB/ y on average for 0 25 - 4 
kHz and could not be explained by presbyacusis alone. 
Conclusion- The USH ΙΒ and USH2A can be easily distinguished by heanng impairment at 
age younger than 40 years at the low frequencies. Heanng impairment in our patients with 
USH2A should be charactenzed as progressive. 
Introduction 
The Usher syndrome was first descnbed in 1858 and charactenzed as a disorder with 
bilateral sensonneural heanng loss and visual impairment caused by tapetoretinal 
degeneraton.' Several authors emphasized a high prevalence of this syndrome in certain 
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families and a hereditary nature was suspected. Von Wibout suggested that the syndrome 
had an autosomal recessive mode of inheritance.2 
Clinical heterogeneity within the syndrome was first descnbed by Bell.3 Later, Hallgren 
pointed out that at least two distinct clinical types existed.4 Extensive clinical studies have 
been performed to outline the clinical heterogeneity Three clinical types, Usher type I, II 
and III, were distinguished, which was important for counseling purposes and gene linkage 
studies.5 
As early as 1959 already, Hallgren suggested that the different clinical subtypes were related 
to different genetic subtypes.4 Since 1990, linkage studies by several groups have 
demonstrated extensive genetic heterogeneity within the Usher syndrome. Usher syndrome 
type I consists of six genetic subtypes (USHIA through F), whereas Usher syndrome type II 
has 2 genetic subtypes (USH2A- and B).6"12 Usher syndrome type III has been linked to only 
one locus sofar (USH3) and is mainly diagnosed in Finland.13 In the Netherlands and Belgium, 
USH ΙΒ and USH2A are most frequently encountered. 
In 1995, mutations in the human myosin VIIA gene were found to be responsible for 
USH I B.M Recently, Eudy et al. reported on a gene encoding a protein with extracellular 
matnx motifs. Mutations in this gene seem to cause USH2A l5 
Whereas in the past clinical examination was needed for diagnosing the subtypes of Usher 
syndrome, such a diagnosis, at present, will be based mainly on either linkage analysis or 
mutation analysis. This does not disqualify clinical studies on the Usher syndromes These are 
still of considerable importance to explain some of the relevant differences in phenotypes 
based on different genotypes. By this an understanding of the related pathophysiology could 
be gained. 
Patients and Methods 
In this study, 19 patients ( 14 men, 5 women; mean age 27 years) with Usher syndrome type 
I and 27 patients ( 13 men, 14 women; mean age 38 years) with the Usher syndrome type II 
were examined. All patients, except for 2 isolated cases, either had I or more affected 
siblings or their parents were consangumeously related The patients and their families were 
living in the Netherlands or Belgium 
Genetic subtypes of Usher syndrome were determined by linkage analysis or mutation 
analysis. Two isolated cases of Usher syndrome could be included because their genotype 
was confirmed by mutation analysis. Pathogenic mutations in the myosin VIIA gene on 
chromosome I I q 13 (USH IB) were detected in 7 type I families ( 12 patients) and in I 
isolated case. The other 3 type I families (6 patients) showed linkage to 11 q 13 (USH IB) and 
are still being analyzed All 14 type II families, as well as the other isolated case, showed 
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linkage to chromosome Iq32 (USH2A). Linkage to USH3 (chromosome 3q) was excluded 
in these cases. Eudy et al. recently found mutations in a gene encoding a protein with 
extracellular matnx motifs that seemed to be responsible for USH2A l5 In 6 type 2A families 
( 10 patients) in this study, as well as in the isolated case, the 2314delG mutation in this gene 
was demonstrated 
Clinical examination of the affected patients included medical history, audiovestibular testing 
and ophthalmologic examination. The latter included external eye examination, corrected 
visual acuity measurements, slit lamp microscopy, ophthalmoscopy, Goldmann penmetry, 
electroretmography and eletro-oculography The results of ophthalmologic examinations 
confirmed the diagnosis of tapetoretinal degeneration in all patients with type ΙΒ and 2A l6 
Electronystagmography was performed to evaluate vestibularly-evoked and visually-guided 
eye movements; it disclosed vestibular areflexia in all patients with Usher type IB, whereas 
vestibular responses could be elicited in all patients with Usher type 2A 
Audiometnc evaluation of 26 patients with USH2A was performed at the Department of 
Otorhmolaryngology, University Hospital Nijmegen, Nijmegen, The Netherlands. It 
consisted of standard pure tone audiometry, assessment of speech discnmination scores and 
audrtory brainstem responses. The audiometnc data of I patient with USH2A were obtained 
from elsewhere. In 17 patents with USHIΒ pure tone audiometry was performed at the 
Department of Otorhmolaryngology in Nijmegen. Heanng impairment in these patients was 
too severe to yield any meaningful speech discnmination scores or auditory brainstem 
response data. We obtained pure tone audiograms of 2 patients with USH IΒ from 
elsewhere. Pure tone audiometry of the best ear at the last visit was used for a cross-
sectional companson of heanng impairment in USH ΙΒ and USH2A Pure tone audiograms 
were measured with a clinical audiometer (AC40, Interacoustics, Assens, Denmark) 
according to the International Organization for Standardization 8523-1 standard ( 1989) at 
0.25, 0.5, 1, 2, 4 and 8 kHz for air and bone conduction. 
Because residual heanng in USH IΒ is only detectable in the low frequencies and no 
thresholds could be measured in the high frequencies, it was not possible to determine a 
pure tone average heanng loss for all frequencies. We therefore evaluated heanng 
impairment for each frequency separately. Furthermore, a method had to be found to 
visualize the nonmeasurable thresholds and the observed vibro-tactile sensations in 
audiogram format. Out-of-scale thresholds (> 130 dB), or thresholds that could be attnbuted 
to vibro-tactile stimulation instead of auditory stimulation were set at the vibro-tactile 
thresholds for 0.25, 0.5, I 0 and 2.0 kHz (95, 115, 125 and 130 dB, respectively).I7 At 4 
and 8 kHz out-of-scale thresholds were set at 130 dB. Obviously, the distnbution of 
thresholds in USH IΒ was nongaussian and further statistical analysis with regard to heanng 
impairment in this population was not applicable. 
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Heanng impairment m USH2A was compared with that in USHIΒ to see whether these 
genotypes can be distinguished by their heanng impairment. W e also looked for progression 
of heanng impairment in the patients with USH2A. A linear regression analysis was applicable 
to model heanng impairment related to age m USH2A at each frequency, except for 8 kHz, 
because data were biased by out-of-scale thresholds. A longitudinal study on individual 
USH2A data had already proved that USH2A can be progressive in some cases. ieThe 
USH IΒ threshold data did not permit a cross-sectional analysis by means of regression 
analysis W e analyzed the longitudinal data in 7 patients with USH IB. When progression of 
heanng loss was analyzed, the threshold values were also corrected for presbyacusis. The 
50th percentile threshold values for presbyacusis, corrected for age and sex, were calculated 
according to the International Organization for Standardization 7029 method ( 1984). 
Results 
All patients with USH IΒ had residual heanng only at the lower frequencies, whereas the 
patients with USH2A generally showed a down-sloping audiogram. Figure I shows the 
audiogram data of all cases. 
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The astensk indicates a 56 y old patient with USH2A, who was been excluded from the 
statistical analysis because of excessively good heanng threshold which strongly affected the 
overall results of the USH2A group The average audiogram slope was about -10 dB/octave 
m the USH2A group. There was a wide separation between the data points pertaining to 
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each type of Usher syndrome at each frequency. Because in the patients with USH IΒ the 
distnbution of thresholds was clearly nongaussian at most frequencies, we based the 
classification by threshold only on the threshold distnbution in patints with USH2A. The 95th 
percentile thresholds in type 2A as well as the minimum values of USH IΒ are indicated in 
the Table 
Table 
Statistics of 
hearing 
threshold (dB 
HL) related to 
age in USH IΒ 
andUSHM 
ATI annual 
threshold 
increase (dB/yj 
Italics indicates 
heanng 
impairment 
parameters after 
correction for 
presbyacusis (-
50th percentile, 
Pu,) 
Frequencies 
USHIB(n= 
mm value 
USH2A(n= 
mean ± SD 
p* 
ATI (dB/y) 
Y intercept 
-p» 
ATI(dB/y) 
Y intercept 
19) 
26) 
0 25 kHz 
80 
36 7 3 ± I 4 49 
61 
081 
5 70 
0 70 
745 
0 5 kHz 
95 
50 96+14 63 
76 
0 75 
22 01 
063 
24 16 
1 kHz 
120 
65 77± 
93 
0 66 
40 24 
053 
4256 
2 kHz 
120 
1592 72.88±I47I 
98 
0 58 
50 65 
034 
5570 
4 kHz 
130 
78 08± 18 23 
109 
0 75 
49 36 
031 
5924 
This analysis ignored the possible influence of age on hearing threshold Figure 2 shows the 
plots of thresholds against age for the 2 types of Usher syndrome at each frequency 
Regression lines are shown only for the patients with USH2A, because the USH IΒ threshold 
data were nongaussian at most frequencies It is clear, however, that the latter did not show 
any appreciable dependence on age. The USH2A can be optimally distinguished from 
USH IΒ at age younger than 40 years, according to the criterion that m USH2A the 
maximum tolerable thresholds are 70, 80 and 100 dB at 0.25, 0.5 and I kHz, respectively 
(dotted lines). 
There was significant progression in heanng impairment, ι e. the regression coefficient - here 
called annual threshold increase - differed significantly from zero, in the patients with USH2A 
at all frequencies (Figure 2, Table) Regression analysis (analysis of variance) showed that the 
annual threshold increases at 0 25 - 4 kHz were not significantly different (pooled value 
about 0.7 dB/y), but the intercepts (decibel heanng level at age X = 0) differed significantly 
from 0, except at 0.25 kHz. The intercepts tended to be higher at the high frequencies, ι e 
assuming that the linear regression applies to the whole age range 
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A longitudinal analysis on 13 patients with USH2A included in this study was previously 
performed by van Aarem et al ι β From these data, they concluded that in individual cases, 
USH2A can show progression in heanng impairment. We also performed a longitudinal 
analysis on progression of residual heanng of 8 patients with USHIΒ (data not shown), but 
found no evidence of any substantial progression in heanng impairment 
Discussion 
Heanng impairment has been regarded to be different in Usher type I and type II since 
definition of these clinical subtypes. Patients with Usher syndrome type I have been said to 
see themselves as deaf people going blind, whereas those with Usher type II regard 
themselves as visually impaired individuals with a heanng problem." This acknowledges the 
pertinent difference between the prelmgually profoundly deaf patient with Usher type I and 
the moderately to severely heanng impaired patient with Usher syndrome type II Many 
authors have used only descnptive terms to charactenze the difference in heanng 
impairment between patients with Usher type I and Usher type II. Moller et al20 performed 
quantitative evaluation of hearing thresholds in 9 patients with Usher type I and 16 with type 
II and found a pure tone average in the type II ranging from 53 - 80 dB Fishman et al21 
measured thresholds of 40 dB to more than 90 dB in patients with Usher type II Pakannen 
et al22 compared Usher syndrome type III with type I and II and found mean heanng 
thresholds of about 90, 100, 105 and MO dB at 0.25, 0.5, I and 2 kHz, respectively, in 79 
patients with Usher type I Heanng impairment in our USH IΒ population seemed to be 
more severe with minimum heanng thresholds of 80, 95, 120 and 120 dB at 0.25, 0.5, I 
and 2 kHz, respectively. When analyzing the data from patients with Usher syndrome type II, 
Pakannen et al22 reported heanng thresholds between 40 and 90 dB Our patients with 
USH2A showed similar thresholds at the low frequencies but higher thresholds at the higher 
frequencies 
It proved possible to distinguish USH2A from USH IΒ by means of a simple audiogram 
cntenon This cntenon applies only to patients aged younger than 40 years and the low 
frequencies (0.25- I kHz). Higher ages and frequencies are mappropnate because of the 
relatively strong influences of progression and presbyacusis, which caused considerable 
overlap in threshold values between the two types. Exclusion of I patient with USH2A, who 
had excessively good hearing thresholds did not have any favorable effects on these results. 
We wished to find out whether apparent progression in heanng impairment could be 
attnbuted to presbyacusis. We therefore also corrected each patient's threshold at each 
frequency by subtracting the 50th percentile presbyacusis threshold appropnate for the 
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patient's age and sex. An informal, tentative linear regression analysis was used since a formal 
analysis was not permitted because the data were clearly biased by the presbyacusis 
correction. The results obtained indicated that progression was still detectable in the 
corrected threshold-on-age data at 0 25 - I kHz, but less so at 2 - 4 kHz (Table ). It can 
therefore be concluded that the patients with USH2A as a group disclosed progression in 
heanng impairment that could not be explained by presbyacusis alone 
The rate of progression, annual threshold increase, in the present cross-sectional analysis of 
patients with USH2A seemed somewhat higher than the average progression in a 
longitudinal analysis of these patients "This might be explained by the fact that a single, last 
visit threshold measurement tends to be more influenced by presbyacusis than are 
longitudinal measurements at a relatively young age. 
In the patients with USH2Athe rate of progression was fairly similar at all frequencies, with 
an annual threshold increase of 0.7 dB/y on average, but the intercepts, which we will call 
offset thresholds here, were different between the frequencies The higher frequencies were 
clearly more affected at a very young age m USH2A. 
We conclude that, not unexpectedly, patients with USH2A and USHIΒ can be easily 
distinguished by their heanng impairment at the low frequencies and at age younger than 40 
years. This study shows that heanng impairment in our patients with USH2A can be 
charactenzed as progressive If this applies to all patients with USH2A, the phenotype 
probably needs to be redefined 
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Visual impaimnent related to age in Usher syndrome type ΙΒ and 2A; 
a mathematical-statistical comparative analysis 
M Wagenaar, Ρ L M Huygen, AJ L G Pmckers A van Aarem, WJ Kimberimg 
CWRJ Cremers 
Abstract 
Objective- Evaluation of visual impairment related to age in the two most common genetic 
subtypes of Usher syndrome, USH ΙΒ and USH2A 
Methods- Cros-sectional analysis of corrected visual acuity and visual field efficiency related to 
age in patients with genotypes determined by linkage-, mutation analysis Patients or their 
parents were also asked about the age of the affected individual at onset of night blindness 
The relationship between vision parameters and age was evaluated using regression analysis 
Estimates were obtained for the rate of detenoration and the age at onset of visual 
impairment 
Results- Mean ages at onset of night blindness, visual acuity loss and visual field impairment 
were approximately 6-8 y earlier in type ΙΒ (7, 0 and 7 y) than in type 2A ( 13, 8 and 13 y), 
the difference was significant for night blindness and visual field impairment, but not for visual 
acuity loss Mean visual acuity loss to be expected in 10 y was about 0 2 in either type It was 
estimated that a reduction of visual field efficiency by half would take about 13 y in either 
type 
Conclusions- Progression of visual impairment tends to be similar in USH ΙΒ and USH2A but 
has an earlier onset in USH IΒ Visual impairment progression m USH2A tends to have a 
greater vanability than in USH IΒ 
Introduction 
Usher syndrome is a group of autosomal recessively inherited disorders charactenzed by 
bilateral congenital sensonneural heanng impairment and progressive pigmentary 
retinopathy 
91 
Chapter 4 
The clinically heterogenous picture of this syndrome has been categorized by Davenport 
In this classification, Usher type I is defined as profound congenital sensorineural hearing 
impairment with an early onset of a pigmentary retinopathy and absent vestibular responses 
Type II is characterized by non-progressive mild to moderate heanng impairment, later onset 
of pigmentary retinopathy and intact vestibular function In Usher syndrome type III, both 
heanng and vision are normal or nearly normal initially, but detenorate over several decades 
Genetic studies have further subdivided the clinical types Usher type I consists of six different 
genetic subtypes (USH I Α-F), whereas Usher type II has two genetic subtypes (USH2A-B)3 
9
 Type III has mainly been diagnosed in Finland and showed linkage to chromosome 3q 
(USH3) l0 USH ΙΒ and USH2A are most frequently encountered and of both types the gene 
has been identified " l2 
The gene responsible for USH IΒ encodes the human myosin VIIA " Expression of myosin 
VIIA in the retina was seen in the photoreceptor cells of 28 week-old human embryosl3 The 
highest concentration of myosin was found in the region of the connecting ahum, which links 
the inner and outer segments of the photoreceptor cell M It has been suggested that myosin 
VI IA has a function in the transport of newly synthesized proteins along the length of the 
connecting cilium to the site of the disk membrane assembly Myosin VI IA might also help 
maintaining the diffusion barner between inner and outer segments, which is necessary to 
protein transport from the inner to the outer segment Such a mechanism suggests that 
defects in the myosin gene hamper photoreceptor function from its first expression, possibly 
leading to early retinal degeneration Visual system manifestations nevertheless seem not 
apparent throughout the first years of life in contrast to audiovestibular impairment 
In USH2A, mutations have recently been found m a gene encoding a protein with 
extracellular matnx motifs l2 Especially the mterphotoreceptor matnx seems to be neh in 
these extracellualr matnx proteins The mterphotoreceptor matnx occupies the subretmal 
space between the photoreceptor and the retinal pigment epithelium l5 It takes care of 
retinal adhesion to the retinal pigment epithelium and it creates a domain around single 
photoreceptor cells, which seems to be vital to their function It is as yet difficult to estimate 
the effect of defective extracellular matnx proteins, but it is possible that they hamper the 
structure and function of the mterphotoreceptor matnx Disorders of the mterphotoreceptor 
matnx may cause disturbances of the photoreceptor layer by affecting retinal adhesion and 
the release of lysosomal enzymes to photoreceptors This could lead to retinal degeneration 
and/or detachment 
In this respect it is of interest to report that giant retinal tears have been discnbed in Usher 
type II patients Only six cases of giant retinal tears and retinitis pigmentosa have been 
reported in literature In all but one, the patients had Usher syndrome type II l6 
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Now that it is possible to determine the genotypes of the two most common subtypes of 
Usher syndrome, it may be important to reevaluate clinical data Relating clinical data and 
genetic subtypes of Usher syndrome to hypothesis as mentioned above may learn us more 
about the pathophysiology and help us informing the patient about his prognosis 
Patients and methods 
In this study, 19 patents from 10 families with Usher syndrome type IΒ and 26 patients from 
12 families with Usher syndrome type 2A were examined Patients had either one or more 
affected sibs, or had parents who were consanguineously related All families are living in The 
Netherlands or Belgium Blood samples from the patients and their relatives were sent to 
Boys Town National Research Hospital for genetic evaluation Pathologic mutations in the 
myosin VIIA gene on the chromosome 11 q 13 locus have been detected in 7 type I families 
The other three families showed linkage to chromosome I I q 13 and are still being analyzed 
All 12 Usher type II families showed linkage to chromosome Iq32 (USH2A) Linkage to 
chromosome 3q was excluded in these families Recently, mutations have been found in a 
gene encoding a protein with extracellular matnx motifs which is considered to be 
responsible for USH2A l 2 In four USH2A families the common 23 14delG mutation was 
found 
Audiovestibular examination revealed profound heanng impairment and vestibular areflexia in 
all type ΙΒ patients The type 2A patients had mild to moderate heanng impairment 
Vestibular responses could be elicited and ranged from normal to hyperreflexic3 
Ophthalmologic examination included external eye examination, corrected visual acuity 
measurements, slit lamp microscopy, ophthalmoscopy, Goldmann penmetry, 
electroretmography and electro-oculography When companng type ΙΒ and type 2A, we 
focused on the onset of night blindness, the onset and progression of corrected visual acuity 
loss and of visual field loss Visual field loss was expressed as the field efficiency (%) for the 
V-4 isopter according to the method descnbed by Fishman et al " Patients of vanous ages 
(range 8-59 years) were studied Last-visit measurements of their best eye were used for 
cross-sectional analysis of age-dependent progression of visual impairment Longitudinal data 
although available in some of the cases, were too limited in number of examinations and 
time interval covered They did not allow for more than a gross check on the results of the 
cross-sectional analysis Both individual longitudinal analyses and cross-secbonal analysis of 
visual field impairment were previously performed by others in a group of patents with 
retinitis pigmentosa (RP) l921 
By establishing a mathematical relationship between age and visual acuity or visual field 
efficiency, we obtained estimates for the rate of detenoration of the visual parameters from 
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the slopes of the regression lines (Figure 2, 4). The age at onset was estimated by 
extrapolating the regression line back to the age at which, presumably, detenoration had just 
begun." These findings were compared with the onset ages of night blindness. 
Details about the statistical methods are given in the results section and the appendix 
Outliers were identified by applying Chauvenet's cntenon." The means of any two vanables 
were compared using Student's t test. Welch's t' statistic was used if the variances of the two 
vanables differed significantly (F test)2 3 A commercial program was used for the regression 
analysis (Prism, version 2.0, GraphPad, San Diego, USA) Regression lines pertaining to type 
ΙΒ and type 2A were compared using the F test of this program The program stops testing if 
the slopes of the regression lines appear to be significantly different 
Results 
Night blindness 
Figure I 
The numbers of 
type IΒ and 
type 2A patients 
with onset of 
night blindness 
at a given age 
Astensk indicates 
outlier 
# patients 
DUsher type IB Bllshei type 2A 
H I ι 
20 22 2& 26 
onset age (y) 
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The parents of the patients and/or the patients were asked about their age at the onset of 
night blindness Figure I shows the distnbutions of onset age Night blindness occurred 
significantly earlier (5 5 y) in type ΙΒ than in type 2A patients (Table I ) 
Table I 
Statistics of the 
age at onset of 
night blindness 
in Usher type 
ΙΒ and type 2A 
(significant values 
in italic face) 
USHIBfn= 
mean 
SD 
USH2Afn= 
mean 
SD 
t = 5 48 
15) 
19) 
age at onset 
(y) 
7 1 
23 
126 
33 
Corrected visual acuity and age 
The corrected visual acuity (VA) in both groups of patients decreased significantly with age, 
the regression lines pertaining to type ΙΒ and 2A were not significantly different (Figure 2, 
Table 2) The statistics for the linear regression of corrected visual acuity of the best eye on 
age are shown in Table 2 Estimates of the mean and standard deviation (SD) of the age at 
onset ( t ^ J of detenoration of VA and the rate of detenoration of the VA were denved from 
the intercept (VA when t = 0 y) and the regression coefficient in Table 2 by applying the 
transformation formulas (Table Al of the Appendix) 
Table 2 
Stamcsforthe
 u 5 H | B ( n = | 7 y 
linear regression 
of visual acuity in mean 
the best eye on SD 
age(y) 
(signficant values U S H 2 A ( n = 2 4 ) 
in italic face)
 mean 
SD 
test result 
pooled value 
Correlation 
coefficient 
Regression 
coefficient (y ') Intercept tom(y) t V A , 0 5(y) 
-072 
-076 
Ό0Ι5 
0 004 
-0018 
0 003 
not significant 
-0017 
100 
0 10 
1 15 
0 13 
not significant 
1 09 
0 2 
0 1 
83 
1 5 
32 6 
θ 1 
36 3 
6 5 
exd'age(y)/VA, 26/0 I and 36/08, 
excl'age(y)/VA, 35/1 and 40/1 
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The ages at onset (Figure 2, downward arrows) differed by about 8 years between the two 
types The findings in type IΒ suggest that onset of detenoration of VA might start even soon 
after birth The ages at which the corrected visual acuity was 0 5 (Figure 2, oblique arrows) 
were fairly similar in both types (32 6 and 36 3 y, respectively) 
Figure 2 
Corrected visual acuity (VA) of 
the best eye related to age (y) in 
Usher type IB and type 2A The 
regression lines for type IB 
(continuous) and 2A (dashed) are 
shown They are not significantly 
different as can also be 
appreciated from the fairly similar 
dispersion of data points The 
Arabic figure 2 indicates two 
identical data points 
. t 
n
 Usher type I B " U s h e r type 2A 
age (y) 
Figure 3 
Visual field efficiency (FE, in 96) of 
the best eye related to age (y) in 
Usher type IB and type 2A 
patients Lines indicated as in 
Figure 2 
Figure 4 
Plot ofln(FE/IOO%) related to 
age (y) in Usher type IB and type 
2A patients Same symbols and 
layout as in Figure 2 The 
regression lines show fairly similar 
slopes but clear separation of 
data points 
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Visual field efficiency and age 
The visual field efficiency (FE) in both groups of patients decreased wrth age, but the 
relationship appeared to be more complex than in the case of visual acuity loss (Figure 3) By 
taking the natural loganthm (see previous studies on retinitis pigmentosa patients ) we 
produced data suitable for (log)linear regression analysis (Figure 4) The curves in Figure 3 
were plotted with the parameter values obtained from the regression analysis (Table 3), 
which relate to the logarithmic transformation shown in Figure 4 A possible explanation as to 
why the logarithmic transformation of the field efficiency may be appropnate in relation to 
age is given in section 2 of the Appendix The slopes of the regression lines pertaining to 
USHΙΒ and USH2A showed no significant differences, but the intercepts (relating to FE at t = 
0) were significantly different This indicates separation between the USH ΙΒ and USH2A 
data points (Figure 4) 
The statistics for the intercept indicate that some of the Usher type 2A patients may have had 
some constnction of their visual fields already at a very young age (Table 3) There is no such 
indication in type IΒ despite a lower onset age, which is probably explained by less 
vanabilrty Visual field progression m USH2A tends to have a greater vanability than in 
USH IΒ 
'Half life' can be calculated as 0 693/k ( = t f ^ ^ , ^ ,see section 2 of the appendix) The 
values obtained imply that in type ΙΒ and 2A, from any given age onwards, the FE will have 
detenorated to one half after about 13 years 
Table 3 
Staùstics for the 
regression of 
ln(FE/IOO%)of 
the best eye on 
Correlation Regression 
coefficient coefficient (-k) (y ') Intercept (kt^J U t f j - ^ 
USH IΒ (n= 15)' 
mean 
age (yXsignificant SD 
values in italic 
face) ySH2A(n=2l) b 
mean 
SD 
test results 
pooled value 
-095 
-072 
-0058 
0 006 
-0050 
0011 
not significant 
-0 053 
041 
0 16 
0 66 
0 43 
significant 
not applicable 
70 
28 
13 1 
9 1 
190 
I 8 
26 9 
59 
exd age(y)/FE (%), 9/42, 23/92, 24/98, 26/12 
" exd age(y)/FE (%), 20/19, 22/18 
Companson of the age at onset of night blindness, visual acuity loss and visual field loss 
We compared the vanous ages of onset in type ΙΒ and type 2A (Table 4) There was no 
significant difference between the age at onset of night blindness and visual field loss in either 
of the two types In type IB, the difference between the mean age at onset of visual acuity 
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loss and the age at which night blindness as well as visual field loss were noticed (difference 
6.8-6.9 y), was significant (t' = I I .66 and 9.16, respectively). In type 2A, the difference in 
onset age between visual acuity loss and that of night blindness was significant (4.3 y; t' = 
5.13), as was the difference between the mean onset age of visual acuity loss and that of 
visual field loss (4.8 y; t' = 2.34). 
Table 4 USH ΙΒ USH2A 
Synopsis of 
findings in Nigth blindness 
USH IΒ and . ... 
mean age at onset (y) 
95% range 
Corrected visual acuity loss 
mean age at onset (y) 
95% range 
meanageVA=05(y) 
95% range 
mean decrease per 10 y 
95% range 
Visual field loss 
mean age at onset (y) 
95% range 
mean age^so*, (y) 
95% range 
mean "half life" (y) 
95% range 
7 
3-12 
02 
0-0 4 
33 
15-50 
02 
0 1-0 25 
7 
1-13 
19 
15-23 
12 
9-14 
13 
6-20 
8 
5-12 
36 
23-50 
02 
0 1-0 25 
13 
0-32 
27 
15-39 
14 
7-20 
Discussion 
Onset of night blindness 
Our data on onset age of night blindness in USH ΙΒ and USH 2A (Table 4) are fairly similar 
to those reported by Moller et al., who found a mean onset age of 8 y (range 2-14 y) in 
Usher type I and 14 y (range 9-21 y) in Usher type II.2'' Matthews et al. mentioned that in 
type I the age at onset was before 15 y, whereas in type II the age at onset varied between 5 
and 31 y.25 Fishman et al. reported that type II showed an onset of night blindness in the 
latter part of the second decade or at the beginning of the third decade, whereas m Usher 
type I, night blindness was encountered within the first decade or at the beginning of the 
second decade." Our data on USH IΒ agree with Fishman's indication of the onset of night 
blindness in type I, but they revealed a younger onset age in type 2A compared to the 
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reported type II. Previous studies in literature did not specify any genotypes 
Moller et al. suggested that Usher type I patients tended to notice their night blindness earlier 
because of their vestibular areflexia.24 Indeed, type I patients may feel more uncomfortable in 
a dark environment for this reason The present results indicate an early onset of visual field 
loss, which might also contnbute to discomfort in the dark and therefore be an additional 
reason for earlier detection 
Corrected visual acuity and age 
Our regression analysis revealed a fair similarity between type ΙΒ and type 2A, despite the 
apparent dissimilanty in onset age (Table 4). 
Fishman et al. found no significant difference in the age-dependent changes of visual acuity 
between type I and type II patients.18 A study by Piazza et al. indicated that visual acuity loss 
up to a certain degree occurred at a significantly younger age in type I.26 Most recently, 
Edwards et al. demonstrated that visual acuity was significantly worse in type I patients than in 
type II patients, especially in the 3rd and 4th decade of life.27 None of the previous studies in 
literature specified any genotypes 
It is important to bear in mind that by establishing the age at onset by extrapolation, a 
theoretical approach is applied. We are aware that an individual's visual acuity soon after birth 
is not yet compatible with the optimal visual acuity that will develop over the years The 
present findings nevertheless suggest that some of the patients may already have impaired 
foveal receptor function at a very young age, thereby hampenng optimal development of 
visual acuity Fishman et al. reported that foveal lesions could be found at a younger age and 
that the probability of exhibiting an atrophic- or cystic-appearing foveal lesion increased with 
age in both type I and type II patients.28 The analysis of the rate of development of foveal 
lesions against age performed by these authors revealed similar rates in type I and type II, 
which agrees with our finding of fairly similar detenoration rates of visual acuity 
The present and previous studies used group statistics on patients of vanous ages. It should 
be emphasized that, in general, in order to reach any firm conclusions, a thorough analysis is 
required based on sufficient longitudinal data from individual patients. Inspecton of our 
incidental longitudinal data (not shown) revealed that these generally supported the present 
findings. 
Information denved from Table 2 and Figure 2 may be of help when informing an Usher 
patient about the prognosis of his corrected visual acuity. For any given patient with a certain 
corrected visual acuity, an estimate can be made of the visual acuity (and 95% range) that can 
be expected in 10 y (Table 4) 
Visual field efficiency and age 
Similar to previous studies, logarithmic regression was appropnate to model the relationship 
between field efficiency and age " 2 1 2 7 Our regression analysis disclosed significant separation 
between USHΙΒ and USH2A data. Moller et al. reported that they failed to find any 
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difference in the progression of visual field loss between type I and type II patients M Edwards 
et al found significant separation between type I and type II patients, with also more visual 
field impairment, at a given age, in the type I patients27 Genotypes were not specified 
Information obtained from Table 3 and Figure 3 may be of help when trying to estimate the 
patient's visual field loss 'Half life' estimates give and impression of how many years it may 
take for a patient's field efficiency to be reduced by half (Table 4) 
Again we state that an analysis of longitudinal data from individual Usher patients would be 
worthwhile in order to reach any firm conclusions Given the slow rate of progression of 
visual field impairment in Usher patients, however one can understand that a longitudinal 
study will be difficult to accomplish 
Companson of the age at onset of night blindness, visual acuity loss and visual field loss 
The findings suggest that visual acuity impairment and visual field impairment are relatively 
independent processes, while night blindness is linked with visual field impairment In the 
literature, rt is generally agreed that night blindness precedes visual field loss2 9 3 I 
The difference in dispersion between the data points of USHΙΒ and USH2A that was 
stipulated in the preceding section can be interpreted in terms of either a difference in 
seventy of visual field impairment at a given age (separation m Y direction), or a difference m 
onset age with similar impairment (separation in X direction). Given the plausible link 
between the onset of visual field impairment and that of night blindness and the finding that 
night blindness started earlier in USH IΒ than m USH2A, it seems natural to favour a 
difference in onset as a possible explanation 
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Appendix 
Table AI 
Transformation 
formulas for the 
mean and 
variance of the 
visual acuity 
parameters 
denvedfrom 
the intercept 
(mean a, 
variance V(a)) 
and regression 
coefficient 
(mean b, 
vanance V(b)) 
in the 2. 
regression 
equation 
Calculation of denved parameters from the pnmary regression parameters (example) 
The general linear regression equation is / = a + bx, where a is the intercept (y value at χ 
= 0) and b is the regression coefficient (slope tangent). 
The VA (visual acuity) vs age plot is fitted with this general equation. 
Following an intuitive approach, one would state that from onset age (t^J onwards the VA as 
a function of age can be formulated as; VA(t/) = I + b(t- t^J. It can easily be seen that t and 
VA(t/) correspond with χ and /, respectively; b is unchanged and the intercept a = I - bt^ 
from which follows that t^ = (/-a)/bas is shown in Table A l . 
Parameter Mean Vanance 
VA;t 
VA;t 
FE.t 
FE, t 
(/-aj/b aV(a) + [(C-a)A>î V(b) with C = I 
(0.5-a)/b „ with C = 0.5 
-a/b V(a)/b2 + (a/b2f V(b) 
(In0.5-a)/b aV(a) + [(C-a)/b2j V(b) with C = lnO.5 
Appropnateness of the logarithmic transformation of field efficiency (FE) 
Substituting ln(FE/l 00%) for /and t (age) for x, the equation y = a + for becomes 
ln(FE/IOO%) = a+bt. 
At onset age (t^J, the FE is 100% and thus y = a + bx becomes 0 = a + bt^ from which 
we find ton — -aft* (Table AI ) and a = -bt^ Replacing a by the latter nghthand expression, it 
appears that ln(FE/l00%) = bt-btons. If we substitute -b by £in this equation, the 
expression becomes/ -kt + ktonsor -k(t - tons). It follows that FE/100% = exp[-k(t - tons)]. 
This equation is typical of a flirt-order decrease in the proportion FE/100%. If the latter 
equals the proportion R/Rons, where R stand for the density of retinal elements (or rods) 
involved, the same equation would result from mtergration, if the value of R decreased from 
its value at onset Rons2^ a rate which was proportional to the current value of R by the rate 
constant k, i.e. dR/dt = -kR 
1
 Half life' is found by stating ln(50%/l 00%) = ln(0.5) = -k^,^.^ ) , from which half life = 
fe-sw » . = lnO-5/k = 0.693/k. 
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Ophthalmologic findings in Usher syndrome type 2A 
A van Aarem, M Wagenaar, A J L G Pmckers, Ρ L M Huygen, Ε M Bleeker-Wagemakers WJ 
Kimberlmg, C W R J Cremers 
Abstract 
Thirty-seven patients, compnsmg 24 familial cases and 13 isolated patients with Usher 
syndrome type II (USH2), underwent ophthalmologic examination Based on the degree of 
heanng loss, normal vestibular function and gene-linkage analysis, familial cases were 
assumed to have USH2A An analysis of genetic heterogeneity failed to reveal the presence 
of a second locus in the Dutch population Although the patients appear to belong to a 
genetically homogenous group, remarkable ophthalmologic vanability was found Corrected 
visual acuity decreased with age and remarkable differences in visual acuity was found within 
one family Fundoscopic findings were classified as type A if attenuated vessels and bone 
corpuscles in all quadrants were found or as type Β if findings other than these were found 
The prevalence of type A significantly increased with age 
Introduction 
Usher syndrome is an autosomal recessive disease charactenzed by retinitis pigmentosa (RP) 
and bilateral congenital sensorineural heanng loss or deafness The prevalence of the Usher 
syndrome is estimated at 3 0-4 4/100,000 ' 5 It is the most frequent cause of deaf-blindness 
Based on the clinical symptoms, three different types have been distmquished 
Type I presents with deafness, RP, and loss of vestibular function Type II has a mild to 
moderate heanng impairment, RP, but no vestibular dysfunction Type III is charactenzed by 
progressive sensonneural heanng loss Gene-linkage analysis has subdivided the clinical 
Usher type I into 3 types (USHI A, USHIB, USHIC) ^ USHIΒ has been found to be due 
to mutation in the myosin VIIA gene on chromosome I I q 9 Most Usher type II families show 
linkage to chromosome I q41 (USH2A)10, although a few families have failed to show linkage 
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to this region so far (USH2B) " l2 Usher type III has recently been assigned to chromosome 
3q.13 
All 37 affected patients in this study are of Dutch nationality and were considered to have the 
USH2A based of physical examination and gene-linkage analysis. They were all carefully 
examined to study the vanability in clinical symptoms. Remarkable variability was found in the 
ophthalmological symptoms. Therefore this study focused on the ophthalmologic aspects of 
the Usher syndrome. 
Patients and methods 
In total, 37 Dutch individuals with Usher syndrome type II were included in this study 
Twenty-four patients came from families with more than one affected person (familial cases) 
and/or from families with close consanguinity. These families were listed alphabetically from 
A to Ν and the patients were numbered consecutively. Family H/l is considered to be a 
special family. Patient Η17 is marned to patient I, who is an isolated case of Usher type II. 
They have three children with the Usher syndrome (family I). The other 13 patients of the 
37 patients were the only affected persons in their family. They are called isolated cases and 
are listed I -12B. Case 12A and 12B are monozygous twins (Table I ). 
The diagnosis of the Usher syndrome was confirmed by medical history and otoscopie, 
audiovestibular and ophthalmologic examination. The presence of vestibular reflexes and the 
degree of their sensonneural heanng loss confirmed the clinical diagnosis Usher syndrome 
type II. Blood was sampled from the patients, their sibs and their (grand)parents and sent for 
gene-linkage analysis to Boys Town National Research Hospital (Omaha, NB, USA). All 
familial cases showed linkage to chromosome I q41. No linkage to chromosome 3q was 
found An analysis of linkage heterogeneity of informative families did not support the 
hypothesis that there are cases unlinked to I q41 markers. Thus it is assumed that the familial 
cases as well as the isolated cases are USH2A. 
All patients underwent ophthalmologic examination including corrected visual acuity 
measurement, slit-lamp examination and ophthalmoscopy. One ophthalmologist performed 
the ophthalmoscopy in all the patients in order to obtain consistent results. Visual fields were 
evaluated wrth the Goldmann penmeter, using test targets I-1,1-4, III-4 and V-4. Electro-
oculographic (EOG) and electroretmographic (ERG) examinations were performed as 
previously reported.M l 5 
Statistical analysis was used to venfy the vanability between the two patients groups, i.e. 
familial and isolated cases, and within each group. Differences in the relative frequencies of 
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any feature were tested in a 2x2 contingency table using Fisher's Exact Probability test; the F 
value (cf. Ρ value) is specified only for significant differences (i.e F< 0.05). 
Results 
Figure I 
Corrected visual 
acuity related to 
age for multiplex 
and isolated 
cases (families B, 
QD.F.K) 
The results of the otoscopie and audiovestibular examination of the 13 isolated cases and all 
but 3 familial cases are in accordance with the charactenstics of Usher type II. The results of 
the familial cases have been desenbed previously, in 3 Usher type 2A cases (C5, C6 and 
F11 ) a progressive heanng loss was observed.16 
Table I shows the results of the ophthalmologic examination The corrected visual acuity 
ranged from 1.0 to light perception only. As could be expected, visual acuity decreased with 
age (Figure I ). Cataract formation could be demonstrated in 7 out of the 24 familial cases 
and in 3 of the 13 isolated cases. The most common form of cataract was Cataracta corticalis 
postenor (CCP). 
I multiplex case • isolated case 
VA 
1.2 
0,8 
0,6 
0,4
 1 
0,2 H 
ι • 
0 10 2 0 3 0 4 0 50 6 0 70 age (y) 
It is now generally accepted in all forms of RP that different fundus appearances may be seen 
within families and classifications of disease based on fundoscopic appearances were until 
now not helpful. W e also observed a remarkable vanety of fundoscopic findings in the familial 
cases as well as in the isolated cases. In an attempt to correlate gene linkage results with 
fundoscopic appearance, we classified the fundoscopic findings as type A and type B. A type 
A fundus was defined as being charactenzed by narrow vessels and bone corpuscles in all 
quadrants and could include yellow, grey-white flecks, atrophic patches, or atapetal sheen. 
Findings other than these were called type B. Within a family, type A as well as type Β fundi 
were observed. 
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Table 1 
Results of the 
ophthalmologic 
examination of 
37 Usher type II 
patients 
Patient 
Al 
A2 
B3 
B4 
C5 
C6 
D7 
D8 
E9 
EIO 
FN 
FI2 
FI3 
GI4 
GI5 
HI6 
HI7 
118 
119 
120 
K2I 
K22 
M23 
N24 
Age 
(y) 
48 
44 
55 
40 
35 
38 
27 
24 
25 
20 
37 
35 
26 
54 
51 
50 
45 
22 
21 
20 
51 
43 
38 
59 
Sex 
F 
M 
M 
M 
F 
M 
M 
F 
F 
M 
F 
F 
F 
F 
M 
F 
F 
M 
F 
M 
F 
F 
M 
M 
Corrected visual 
acuity 
OD 0 2 
OS 0 08 
OD 0 3 
OS 0 2 
OD 0 25 
OS 0 4 
OD 1 0 
OS 1 0 
OD 0 5 
OS 0 5 
OD 0 8 
OS 0 8 
OD 0 5 
OS 0 4 
OD 0 5 
OS 0 3 
OD 1 0 
OS 0 8 
OD 1 0 
OS 0 8 
OD 0 4 
OS 0 3 
OD 10 
OS 0 8 
OD 0 8 
OS 0 8 
OD l # 0 0 
OS 1/300 
O D < 0 5/300 
OS<0 5/300 
OD 0 4 
OS 0 3 
OD 0 3 
OS 0 5 
OD 0 6 
OS 0 8 
OD 0 5 
OS 0 5 
OD 0 8 
OS 0 8 
O D < 0 5/300 
OS light pere 
OD 0 5 
OS 0 4 
OD 0 03 
OS 0 4 
ODO 1 
OS 1/30 
Fundus 
A 
A 
A 
Β 
Β 
A 
A 
Β 
Β 
Β 
A 
Β 
Β 
A 
A 
Β 
Β 
Β 
Β 
Β 
Β 
Α 
Β 
Α 
Media 
CCP 
CCP 
CCP 
IO 
CPP 
CC 
CCP 
CPP 
Ν 
Ν 
Ν 
Ν 
CCP 
CCP 
CCP 
IO, large 
vacuole 
CCP 
Ν 
Ν 
Ν 
CE 
CCP 
CSCP 
CSCP 
Goldmann 
OD 5 
OS 5 
OD 10 
OS 5 
OD tv 
OS tv 
OD tv 
OS tv 
OD 20 
OS 20 
OD 10 
OS 10 
OD 20 
OS 20 
OD 25 
OS 25 
ODPRS 
OSPRS 
ODPRS 
OSPRS 
OD 20 
OS 20 
OD 20 
OS 20 
ODPRS 
OSPRS 
OD 30 
OSPRS 
OD tv 
OS tv 
: OD 25 
OS 25 
OD 25 
OS 25 
ODS decr 
sensitivity 
OD 20 
OS 20 
OD Ν 
OS Ν 
ODS n e p 
ODS 25+ 
PRS 
ODS PRS+ 
deer sens 
OD 5 
OS 5 
EOG 
OD 1 08 
OS 1 04 
OD 1 22 
OS 138 
OD 0 67 
OS 0 50 
OD 1 00 
OS 100 
OD 1 II 
OS 1 00 
OD 0 62 
OS 0 60 
OD 1 00 
OS 100 
OD 1 00 
OS 0 88 
OD 0 86 
OS 1 12 
OD 1 10 
OS 1 08 
OD 1 00 
OS 0 83 
OD 0 95 
OS 1 00 
OD 0 95 
OS 125 
OD 0 97 
OS 0 83 
OD 1 00 
OS 1 00 
OD 0 90 
OS 0 86 
OD 1 14 
OS 109 
OD 0 93 
OS 0 95 
OD 1 55 
OS 100 
O D n d 
OSnd 
O D n d 
OSnd 
O D n l r 
O S n l r 
OD 0 94 
OS 100 
OD 1 15 
OS 1 26 
ERG 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
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Patient 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1 1 
I2A 
I2B 
Age 
(y) 
49 
26 
30 
52 
35 
49 
48 
40 
52 
40 
28 
13 
13 
Sex 
M 
M 
M 
M 
F 
F 
M 
F 
F 
F 
M 
F 
F 
Corrected visual 
acuity 
OD 0 08 
OS 0 08 
OD 0 8 
OS 0 8 
OD I 0 
OS I 0 
ODO I 
OS 0 25 
OD 0 6 
OS 0 6 
OD 0 05 
OS 0 05 
OD 0 25 
OS 0 30 
OD 0 25 
OSO 16 
OD I 0 
OS 0 8 
OD 0 4 
OS 0 3 
OD 0 5 
OS 0 5 
OD I 0 
OS 1 0 
OD 1 0 
OS 1 0 
Fundus 
n e p 
A 
Β 
A 
Β 
Β 
A 
A 
A 
A 
Β 
Β 
Β 
Media 
CE 
CCP 
Ν 
CCP 
CSCP 
CSCP 
CSCP 
CCP 
CCP 
Goldmann 
OD 5 
OS 5 
OD PRS 
OS PRS 
OD PRS 
OS PRS 
OD 10 
OS 10 
OD PRS 
OS PRS 
OD 15 
OS 15 
OD 5 
OS 5 
OD PRS 
OS PRS 
OD 10 
OS 10 
NC.CCPOD 10 
CCP 
IO 
CSCP 
Ν 
Ν 
OS 10 
OD PRS 
OS PRS 
nd 
nd 
EOG 
O D n d 
O S n d 
OD < 1 8 
O S < 1 8 
OD 1 00 
OS 1 14 
OD 1 23 
OS 1 33 
OD 1 00 
OS 1 00 
OD 1 33 
OS 0 94 
O D n d 
OSnd 
OD 1 00 
OS 1 00 
OD 1 00 
OS 1 00 
OD 1 04 
OS 1 25 
OD 1 00 
OS 1 00 
OD 1 25 
OS 1 18 
OD 1 25 
OS 1 18 
ERG 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS0 
ODS 
subn 
ODS 
subn 
Media-normal, Ν Cataract extraction CE, Incrensed lens opacification IO, Cataracta corticalis 
postenor CCP, Cataracta polans postenor CPP, Cataracta capsulans CC, Nuclear cataract NC, 
Cataracta subcorticalts postenor CSP, Partial nng scotoma prs, Tunnel vision tv, No light response 
nlr, Decreased sensitivity deer sens, No examination possible nep, Not done nd 
Figure 2 
Distnbution of 
type Β (solid 
bars) and type A 
(hatched bars) 
fundoscopic 
findings per age 
group 
It pat • type A • type Β 
0 20 
JltL 
21 30 31 40 41 50 
age group (y) 51 60 
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Analysis of the ophthalmoscopy results showed that a type A RP fundus was significantly 
more prevalent at a higher age than a type Β fundus (Fig. 2). This difference in prevalence 
was observed in the familial as well as in the isolated cases and in women as well as in men 
Fourteen out of 17 patients with a type A RP fundus were older than 36 years, whilst only 6 
out of 18 patients with a type Β RP fundus were in this age group (F = 0 0043) 
Fundoscopic examination of patient Η17 revealed attenuated retinal vessels, many subretmal 
white punctate deposits and hardly any bone corpuscles· a retinitis punctata albescens aspect 
The patient's children and her sister all had a type Β fundus but no retinitis punctata albescens 
dots. 
Results of Goldmann penmetry ranged from decreased sensitivity to tunnel vision of 5° 
In all the patients, the EOG Lp/Dt ratio was < 1.80 (ranging from 0.50 to 1.55), which 
indicated impairment of the function of the retinal pigment epithelium-rod complex. 
The ERG was extinguished in all the affected persons except for patients 12A and 12B who 
both had subnormal rod and cone function This was in accordance with the early stage of 
their RP. 
Discussion 
Several authors have focused on the similarity and vanabilrty within populations with the 
Usher syndrome. Even before detailed linkage analysis became possible, clinical similarity 
and/or vanabilrty was descnbed within families. 
Hallgren' and Davenport et al.17 descnbed familial similarity only with regard to auditory 
impairment. Bell18 mentioned that retinal pigmentary dystrophy may show remarkable 
mtrafamilial similanty and De Haas et al." also recognized distinct mtrafamilial similarities in 
the ocular disease pattern. 
On the other hand, studies by Nuutila2, McLeod et al.20, Fishman et al2 I and Bateman et al2 2 
all stated mtrafamilial vanabilrty with regard to the audiovestibular and/or ophthalmologic 
features (Table 2) Fishman et al.21 examined 24 Usher type I patients and found no 
mtrafamilial variability with regard to the level of ocular, cochlear and vestibular impairment 
However, when he examined 16 Usher type II patients, he observed mtrafamilial variability 
in the degree of heanng impairment, penpheral field loss, and fundus pigmentations. 
no 
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Table 2 
Survey of the 
literature on 
clinical vanability, 
similarity in the 
Usher syndrome 
otology 
author year type 
heanng 
loss 
vestibular 
function 
ophthalmology 
onset 
nyctalopia perimetry fundoscopy 
Bell18 
Hallgren' 
de Haas et al" 
Nuutila2 
McLeod et al20 
Davenport et al17 
Bateman et al22 
Fishman et al21 
1922 
1959 
1970 
1970 
1971 
1978 
1980 
1983 
-
-
MI 
1,11 
II 
II 
II 
III 
-
s 
-
s 
ν 
s 
-
SV 
-
-
ν 
-
-
-
-
s-
-
-
s 
s 
V 
-
V 
s-
-
-
s 
-
V 
-
V 
sv 
s 
-
s 
V 
V 
-
V 
sv 
Abbreviations mtrafamilial similarity (S), mtrafamilial vanability (V); no information available (-) 
Visual acuity and visual field 
This study focused on the variability in ophthalmologic findings in a group of Usher type 2A 
patients As illustrated in Figure I, visual acuity decreased with age. Similar results have been 
descnbed by Piazza et al.23 and Fishman et a l 2 I To compare our data with these latter 
studies, linkage data of these Usher patients should have been available. Within a family, 
remarkable differences were found in corrected visual acuity This may be due to cataract 
formation (family B), but it also depends on the functional mtegnty of the macular area. As a 
result of differences in age, it is not possible to comment on the variability of the visual fields 
between individual patients. It is common knowledge that constnction of the visual fields will 
progress with age. 
Ophthalmoscopic findings indicated diverse fundus aspects in the examined USH2A patients 
The age-related difference in prevalence between type A and type Β RP fundus aspects was 
statistically significant. A type A fundus may evolve from a type Β fundus with increase in age 
and duration of the desease. This does not exclude the possibility that a type A fundus can 
occur at an early age or that it will never develop, as was indeed found in some of the 
present familial and isolated cases (D7,H 16,H 17,K21,2,6). One reason for clinical 
heterogeneity is that more than one locus causes the disorder. At least two loci are known 
tobe responsable for Usher type II, but the type unlinked to chromosome Iq4l is 
uncommon and there is yet no evidence for its presence in the Dutch population. Hence, it 
seems unlikely that a second locus is responsable for the ophthalmologic vanation observed 
in this study. Another possible explanation is that the clinical variability in fundus aspects 
relates t o the presence of different mutant alleles, as has been descnbed for the PDS gene24 
26
 Within a given family, type A and type Β fundi can be found in sibships of approximately 
the same age (families C, D, F) Differences in the type of alleles involved cannot explain the 
i n 
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variability within these sibships, this variability might be based on differences in genetic 
background or gene interactions27. Environmental influences may also play an important role 
The isolation of the USH2A gene will contnbute to understand the funduscopic variability 
observed m a USH2A population 
Ophthalmoscopic examination of patient H17 revealed retinitis punctata albescens Patient 
H17 is marned to an isolated Usher patient ( I ) All their children are affected with the Usher 
syndrome, which makes it highly likely that the combination of heanng impairment and RP in 
patient H17 is due to Usher syndrome Nuutila2 also descnbed retinitis punctata albescens in 
3 out of 47 patients with dystrophia retinae pigmentosa - dysacusis syndrome, a synonym for 
Usher syndrome Retinitis punctata albescens seems to occur as a variant form of RP 
classically observed in the Usher syndrome 
This study demonstrates that the ophthalmologic symptomatology in an USH2A population 
can vary widely Generally, retinal pigmentation and vascular attenuation in all quadrants of 
the fundus increase with age The relation between visual acuity and age (Figure I ) will be 
helpful when counseling patients with USH2A However, long-term follow-up of these 
patients would be worthwhile to evaluate the clinical course and establish whether the 
genetic background plays a role in the clinical heterogeneity observed 
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The social and scientific relevance of a disorder is often determined by the prevalence of the 
disease The Usher syndrome is said to be relatively uncommon (3-4 per 100 000) but it is 
not the prevalence of this syndrome that asks for social and scientific attention but the 
dramatic loss of heanng and vision causing communication to become more difficult every 
day Slowly all contact with the world around evaporates 
The Usher syndrome with special attention to Usher type I 
Chapter I gives a general descnption of the Usher syndrome, an autosomal recessive 
disorder involving a congenital heanng impairment and visual handicap at a later stage Clinical 
vanabihty within the syndrome has led to classification into three types People with Usher 
syndrome type I are most severely heanng impaired Gene-linkage studies have revealed 
that Usher type I consists of at least 6 different genetic subtypes (USH I A-USH IF) USH IΒ is 
the most common subtype (75%) and is caused by mutations in the human Myosin 7A gene 
Myosin 7A is expressed in the cochlea, vestibule and retina Myosin 7A seems to play a role 
in the function and morphogenesis of stereocilia in the cochlea and connecting cilia of the 
photoreceptors Based on knowledge like this, we seek explanations for example for the 
observed histology of temporal bones and for clinical differences within a subtype 
The studies 
Cft^ote^descnbes the clinical findings in 17 obligate earners of type I Usher syndrome 
Linkage to chromosome 11 q 13 5 was demonstrated in 6 families ( 11 obligate earners) while 
3 families at that time showed mutations in the MY07A gene Obligate earners underwent 
otological, audiological, vestibular and ophthalmological examination The medical history of 
the earners and subsequent otoscopy did not show any relevant abnormalities Eight earners 
had abnormal pure tone audiograms Four of them had increasing heanng impairment, in 
excess of P95, at increasing frequencies The other 4 earners showed decreasing heanng 
impairment at increasing frequencies (including earners with noise trauma) Other auditory 
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tests were all within the normal range. Vestibular responses showed no abnormalities, 
except in 2 earners who had mild unilateral canal pareses. Ophthalmological examination 
showed a significantly lower EOG light peak / dark trough ratio in the earners of Usher type I 
compared to normal controls. No other ophthalmological abnormalities were demonstrated 
It is concluded that audiological and ophthalmological abnormalities can be detected in 
obligate carriers of Usher type I, but the charactenstics are not very specific and therefore 
not suitable for individual earner detection With these data it might nevertheless be possible 
to obtain a modified estimate of the nsk of camership in a clinically unaffected person in a 
family. This information may be incorporated into the lod score, thereby increasing the 
efficiency of genetic mapping efforts in the relatively small autosomal recessive families. 
Using Audioscan audiometry as well as speech discnmmation testing, tympanometry, 
stapedial reflex measurements and auditory brain stem responses (ABR), a study was 
performed to identify more subtle audiological manifestations of heterozygosity. In this study 
transient evoked otoacoustic emissions (TEOAE) were recorded in order to verify notches 
found by Audioscan audiometry Nine Usher type IΒ earners were examined. Results were 
compared to the results of normal controls. Responses to transient evoked otoacoustic 
emissions (TEOAE) were compared to those obtained from age-matched controls from our 
data base and to data in the literature. Audioscan audiometry revealed notches in the 
audiograms of earners, but the prevalence did not differ from that in the control group It was 
possible to venfy these Audioscan notches using transient evoked otoacoustic emissions 
(TEOAE) Responses to transient evoked otoacoustic emissions (TEOAE) in earners were no 
different from the responses found in the age-matched controls. 
It is concluded that in earners of Usher type I no audiological charactenstics were found 
which enabled the specific detection of individual earners. 
Chapter J focuses on a post-mortem study on the histopathology of the temporal bone and 
on a morphometnc analysis of the cochlear nuclei in Usher type I Light microscopic findings 
in the temporal bone of an Usher type I patient as well as the light microscopic and electron 
microscopic findings in a patient with USH ID/IF are desenbed This is the first temporal 
bone report in literature on an Usher patient who has been genotyped. The histopatholoy of 
the temporal bone of the USH I D/l F patient showed the typical picture of cochleo-saccular 
degeneration in contrast with the other Usher patient reported In this patient degeneration 
of the organ of Corti was seen without any clearly visible pathology of the vestibule Both 
patients exhibited atrophy of the stria vasculares and a decrease in the spiral ganglion cell 
population With the help of previous case reports and our present knowledge about, for 
example, the function of myosin 7A, we tned to find an explanation for the observed mter-
and mtra-mdividual differences. Relating the histopathology of the temporal bone to genetic 
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subtypes will, in the near future, tell us whether differences in morphology do indeed result 
from differences in genetic subtypes. 
With the possibility of prosthetc restoration of the congenitally, profoundly heanng impaired 
Usher type I patients, we were interested in the effects of early cochlear degeneration on 
the central auditory system. Brainstem matenal of the two Usher type I patients was 
obtained by routine autopsy before the design of this study was known Unfortunately the 
ventral cochlear nucleus which can easily be damaged dunng routine autopsy, was severely 
damaged in three specimen On 5 of the 8 specimen a morphomertic analysis of the coclear 
nuclear complex and cochlear nerves could be performed. Quantitative data on the cochlear 
nuclei in humans are rare. Therefore the results were compared to data obtained from two 
age-matched controls Slides were examined and estimates were made of the volume, 
neuronal density, number of cells and cell diameter of the dorsal and ventral cochlear nuclei 
Data only suggested a decrease in the mean cell diameter of the ventral cochlear nuclei 
compared to normal controls It is concluded that only minor degenerative changes were 
present in the cochlear nuclei of Usher type I patients despite the fact that they were 
considered to have been sound-depnved since birth. 
In chapter 4 the clinical features of the two most common genetic subtypes of the Usher 
syndrome are descnbed Audiological examination was performed on 19 USHIΒ patients 
and on 27 USH2A patients Mutations in the MY07A gene were found in 12 USH IΒ 
patients Mutations in a novel gene, encoding a protein with extracellular matnx motifs, were 
seen in 10 USH2A patients. Genotypes of the other families were determined by linkage 
analysis. 
USH IΒ patients had heanng loss that was not related to their age Residual hearing, with 
minimum values of 80, 95 and 120 dB at 0.25, 0.5, I kHz, was detected in a few of these 
patients only USH2A patients had mean heanng thresholds that were about 45-55 dB better 
than these minimum values. Heanng impairment m USH2A at age younger than 40 y 
seemed to be charactenzed by maximum heanng thresholds of 70, 80, 100 dB at 0.25, 0 5 
and 1.0 kHz, respectively It is remarkable that USH2A patients as a group showed 
progression of heanng impairment of approximately 0.7 dB per year This progression could 
not be explained by presbyacusis alone 
Ophthalmological examination of approximately the same patient group, consisting of 19 
USH ΙΒ patients and 26 USH2A patients, focused on the visual acuity loss and the visual field 
impairment As night blindness is often the first symptom of retinitis pigmentosa we also 
included this subjective information in our analysis. With the help of regression analyses and 
by extrapolation of the regression lines, an estimate was made of the rate and onset of 
progression of visual impairment. Onset of night blindness, visual acuity loss and visual field 
impairment started approximately 6-8 years earlier in Usher type ΙΒ than in Usher type 2A. 
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It was estimated that visual acuity loss would be 0 2 over a span of 10 years in both types 
Constriction of the present visual field by half would take about 13 years in both types The 
observed differences between USHΙΒ and USH2A were not caused by the fact that retinal 
degeneration in USH IΒ was more severe, but resulted from earlier disclosure of the 
symptoms of retinitis pigmentosa This information might be of importance when advising 
and counselling patients with the Usher syndrome Progression of visual field impairment 
shows greater vanability m USH2A than in USH IΒ 
Ophthalmological examination of Usher type 2A was performed as part of a previous study 
on Usher type II Twenty-four familial cases of USH2A as well as 13 isolated cases of Usher 
type II were included in the study Marked vanability was observed within families All the 
patients underwent fundoscopy, fundoscopic findings were classified as type A if bone 
spicules were found in all quadrants in combination with attenuated vessels All other findings 
were classified as type Β The prevalence of type A fundoscopic findings increased with age 
Conclusions 
With the results from the studies reported in the previous chapters we were able to find 
answers to the questions raised at the beginning of the Nijmegen Usher Project They can 
be summenzed in the following conclusions 
Individual detection of obligate earners of the Usher syndrome type I by means of pure tone 
audiometry and Audioscan audiometry is not specific enough to warrant clinical application 
No specific relationship has been observed between the clinical symptoms of Usher 
syndrome type I and the accompanying histopathology of the temporal bones The histology 
of the cochlea was uniform no matter what type of Usher was involved If abnormalities 
were found in the vestibule, this was more likely to be the case in an Usher type I patient 
than in an Usher type II patient 
Histopathology of the temporal bones in an USH I D/l F patient compromised cochleo-
saccular degeneration 
No major degenerative changes were apparent in the ventral cochlear nuclei and dorsal 
cochlear nuclei of two Usher type I patients who had been deprived of acoustic stimuli since 
birth Data suggested a slight decrease in mean diameter of the cells of the ventral cuchlear 
nucleus 
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Audiological examination showed residual heanng in the low and mid-frequencies in a 
mmonty of the USH IΒ patients in this study. Heanng loss seemed independent of age. 
At age younger than 40 years, USH ΙΒ and USH2A could be distinguished audiologically at 
0 25, 0.5, I kHz, respectively Overlap between USH Ι Β and USH2A was encountered in 
the high frequencies at a more advanced age 
Hearing impairment in our USH2A patients was progressive and could not be explained by 
presbyacusis alone 
An ophthalmological comparison of USH ΙΒ and USH2A revealed that USH IΒ patients were 
equally affected by retinitis pigmentosa, but the degeneration seemed to start at an earlier 
age in USH IΒ (6 -8 years earlier) 
Fundoscopic findings m USH2A patients are charactenzed by a large vanabihty 
The future 
Recent genetic findings may pose a threat to existing clinical and histological classifications 
Daily progress in the genetics of heanng impairment sheds a whole new light on previous 
clinical classifications. Disorders which were regarded as clinically different entities appear to 
be based on genetic similarities, while disorders which were considered clinically similar, do 
not always share the same genetic background 
In this context it is of importance to continuously relate new knowledge to the old. This may 
help to unravel the vanous pathophysiological mechanisms of hereditary heanng impairment 
In case of the Usher syndrome, clinical as well as genetic studies are therefore essential to 
further increase our knowledge of this syndrome. 
In recent times 9 different genetic subtypes of the Usher syndrome have been 
demonstrated. Genes of the two most common subtypes of the Usher syndrome: USH IΒ 
and USH2A, have been identified. It may soon be possible to determine carnership within 
affected families on the basis of genetic analysis This information may enhance the quality of 
genetic counselling. 
Genetic analysis will also enable us to diagnose the Usher syndrome with certainty at very 
young age, which up till now has been very difficult. Thanks to early identification of children 
with Usher syndrome, changes in their development and behaviour can be better 
understood and guidance of a child with the Usher syndrome can be optimized. 
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We wish that by further research into the genetics and clinical features of the Usher 
syndrome we will come to understand the pathophysiological mechanism underlying this 
syndrome. Hopefully, this will eventually lead to a form of treatment for the Usher 
syndrome in the future. 
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Samenvatting en conclusies 
Vaak wordt de maatschappelijke en wetenschappelijke relevantie van een aandoening 
bepaald door de prevalentie van het ziektebeeld. Hoewel wordt opgemerkt dat het 
syndroom van Usher met zéér frequent voorkomt (3- 4 per 100.000), is het met de 
prevalentie die maatschappelijke en wetenschappelijke aandacht vraagt voor deze 
aandoening maar het mgnjpende verlies van het horen en het zien waardoor communicatie 
steeds moeilijker wordt en het contact met de buitenwereld langzaam wegvalt. 
Het Usher syndroom; met speciale aandacht voor Usher type I 
In het eerste hoofdstuk wordt een algeheel beeld gegeven van het syndroom van Usher, 
een autosomaal recessief overervende aandoening waarbij aanvankelijk het gehoor, maar 
enkele jaren later tevens de visus wordt aangedaan. De klinische variatie in dit syndroom 
heeft geleidt tot een Massificatie in dne typen waarbij mensen met het syndroom van Usher 
type I het meest uitgesproken gehoorverlies hebben. Genkoppelmgsstudies in o.a. het Boys 
Town National Research Hospital hebben aangetoond dat Usher type I minimaal 6 genetisch 
verschillende subtypen heeft. Van de mensen met Usher type I behoort 75% tot het 
genetisch subtype USHIB. USHΙΒ wordt veroorzaakt door mutaties in het humane 
myosine 7A gen. Myosine 7A komt tot expressie in cochlea, vestibulum en retina en lijkt een 
rol te spelen in de functie en morfogenese van stereocilia in het binnenoor and connecting 
olia in de retina. In deze studie is geprobeerd om met behulp van deze kennis een verklaring 
te vinden voor de waargenomen histologie van het binnenoor en de klinische vanaties 
binnen het type. 
De studies 
Hoofdstuk 2 beschnjft de klinische bevindingen in 17 obligate dragers van het syndroom van 
Usher type I. BIJ 6 families ( I I obligate dragers) kwam een koppeling met chromosoom 
11 q 13.5 tot stand waarvan bij 3 families tevens een mutatie in het MY07A gen aangetroffen 
werd. 
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Alle obligate dragers werden otologisch, audiologisch, vestibulair en oogheelkundig 
onderzocht. De otologische voorgeschiedenis en het otologisch onderzoek heten geen 
relevante afwijkingen zien. Acht dragers hadden een abnormaal toonaudiogram. Vier van hen 
hadden een toenemend perceptief gehoorsverlies, groter dan de P95, bij toenemende 
frequenties. BIJ de andere vier dragers werd een afname van het gehoorsverlies gezien bij 
toenemende frequenties. Resultaten van andere audiometnsche testen vielen binnen de 
normaal waarden. Vestibulaire responsies waren zonder afwijkingen met uitzondenng van 
twee dragers waarbij een milde unilaterale kanaal parese gevonden werd Oogheelkundig 
onderzoek liet enkel significante afwijkingen bij het EOG onderzoek zien Evenals bij obligate 
dragers van Usher type 2A werd ook bij Usher type I dragers gemiddeld een lagere licht piek 
/donker dal ratio gevonden dan bij normale controles. Audiologische en ophthalmologische 
afwijkingen kunnen bij dragers gevonden worden maar zijn weinig specifiek en daarom met 
geschikt voor individuele identificatie van dragers. Er wordt aangehaald dat bovengenoemde 
afwijkingen er wel toe kunnen leiden dat er een gemodificeerde schatting komt van het nsico 
dat een gezond persoon in een Usher familie een drager is. Deze informatie kan in de lod-
score verwerkt worden en de informativitert van de relatief kleine autosomaal recessieve 
families vergroten. 
Met behulp van Audioscan audiometne en tevens spraakdiscrimmatie audiometne, 
stapediusreflexmetingen, tympanometne en hersenstam audiometne werd gezocht naar 
subtielere audiometnsche manifestaties van heterozygotie. In deze studie werden tevens 
transient evoked otoacoustische emissies (TEOAE) verncht om dips bij Audioscan 
audiometne te venfiëren. Negen obligate dragers, behorende tot USHΙΒ werden 
onderzocht. Resultaten werden vergeleken met resultaten bij controles. Resulaten van 
transient evoked otoacoustische emissies werden vergeleken met een 
leeftijdsovereenkomstige controle groep uit onze databank en met gegevens uit de literatuur. 
Met behulp van Audioscan audiometne bleek het mogelijk dips in het gehoor bij dragers 
(22%) aan te tonen echter de prevalentie verschilde met van de controle groep ( 16%). Het 
was mogelijk dips in Audioscan audiogrammen te venfiëren met behulp van transient evoked 
otoacoustische emissies. Er was geen verschil tussen de transient evoked otoacoustische 
emissies bij dragers vergeleken met de emissies bij de leeftijdsovereenkomstige controles 
Concluderend waren er bij dragers van het Usher syndrome type ΙΒ geen karaktenstieke 
audiologische kenmerken die identificatie van individuele carriers mogelijk maakte. 
Hoofdstuk 3 richt zich op de histologie van het binnenoor en morfometne van de cochleaire 
kernen bij Usher type I. Licht microscopische bevindingen van het binnenoor van een Usher 
type I patient worden beschreven naast microscopisch en eletronen-microscopische beelden 
van het rotsbeen van een USH I D/F patient. Hiermee is dit de eerste rotsbeen beschrijving 
in de literatuur betreffende een Usher patient welke genetisch getypeerd was. Histologie bij 
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deze USHID/F patient liet een beeld van een cochleo-sacculaire degeneratie zien dit m 
tegenstelling tot het beeld dat bij de type I patient werd waargenomen. Deze patient toonde 
het frequent beschreven beeld van degeneratie van het orgaan van Corti zonder duidelijk, 
vestibulair zichtbare pathologie BIJ beide patiënten zagen WIJ verder een atrofienng van de 
stna vasculares en een afname van spirale ganghoncellen. 
Met behulp van casuïstiek uit het verleden, aangevuld met de huidige kennis over onder 
andere de functie van myosme werd getracht een verklanng te vinden voor de 
waargenomen inter en intra-mdividuele verschillen. Koppeling van het genetisch subtype aan 
de histologie van het rotsbeen zal ons hierover, in de toekomst mogelijk meer duidelijkheid 
kunnen verschaffen. 
Omdat beide patiënten sedert hun geboorte geluidsgedepnveerd waren, bestond interesse 
naar de preservate van de centrale auditieve gehoorbanen Hersenstam matenaal van beide 
patiënten was voortianden om een morfometnsche analyse van de cochleaire kernen en de 
nervus cochleans te kunnen vemchten. Kwantrtative gegevens met betrekking tot de 
cochleaire kernen bij de mens zijn schaars Verkregen matenaal is daarom vergeleken met 
matenaal van twee controles van ongeveer overeenkomstige leeftijd. Door de laterale ligging 
van de ventral cochleaire kern wordt deze bij een routine obductie van de hersenstam snel 
beschadigd Helaas werd hersenstam materiaal van controles en patiënten verkregen 
voordat de opzet van deze studie bekend was en bleek bij macroscopische dissectie een 
deel van de ventrale cochleare kernen verloren gegaan te zijn Vijf preparaten in plaats van 8 
preparaten konden in de beoordeling worden opgenomen. Met behulp van morfometnsch 
technieken werden coupes beoordeeld en kon een schatting gemaakt worden van volume, 
neurondichtheid, aantal cellen en gemiddelde somadiameter van de cellen van de dorsale en 
ventrale nucleus cochleans. Data suggereren een afname van de gemiddelde somadiameter 
van de cellen van de ventrale kennen ten opzichte van de waarden gevonden bij controles 
Het volume, de neurondichtheid en het aantal neuronen van de dorsale en ventrale 
cochleare kernen liet geen duidelijke verschil tussen de Usher patiënten en de controles 
zien 
Samenvattend worden er slechts gennge degeneratieve verandenngen aangetroffen in de 
cochleare kernen bij Usher type I patiënten ondanks het feit dat beiden sedert de geboorte 
nauwelijks tot geen restgehoor hadden. 
Hoofstuk 4 schetst het klinisch beeld van de twee meest voorkomende Usher typen; 
USH ΙΒ en USH2A. Audiologisch onderzoek werd verncht bij 19 USH ΙΒ patiënten en 27 
USH2A patiënten Mutaties in het MY07A gen werden inmiddels bij 12 USH ΙΒ patiënten 
aagetroffen Mutaties in een nieuw gen, dat codeert voor een eiwit met extra-cellulaire 
matnx motieven, werden gevonden bij 10 USH2A patiënten Genetische subtypes in de 
andere families werden vastgesteld door middel van koppelmgs analyse. 
De mate van gehoorsverlies bij Usher ΙΒ patiënten was onafhankelijk van hun leeftijd. Slechts 
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in de lage tot midden frequenties kon een rest gehoor gevonden worden met minimum 
waarden van 80, 95 en 120 dB bij respectively 0.25, 0.5, I - 2 kHz USH2A patiënten 
hadden gemiddelde gehoorsdrempels die zo'n 45-55 dB beter waren dan deze minimum 
waarden. Gehoorsverlies bij USH2A leek gekenmerkt te kunnen worden door een 
maximum gehoorsverlies van 70, 80, 100 dB bij respectivelijk 0.25, 0.5 en I kHz op een 
leeftijd jonger dan 40 jaar. Opmerkelijk was dat de gehele groep USH2A een progressie van 
het gehoorsverlies liet zien in de orde van 0.7 dB per jaar. Deze progressie kon met enkel 
verklaard worden door presbyacusis. 
Bovengenoemde patiënten populatie, welke bestond uit 19 USH ΙΒ patiënten en 26 USH2A 
patiënten werd eveneens oogheelkundig onderzocht. Onderzoek nchtte zich op 
achteruitgang van het gezichtsvermogen en de beperking van het gezichtsveld. Daar 
nachtblmdheid vaak het eerste symptoom van een tapetoretinale degeneratie is, werd dit 
ovengens subjectieve gegeven wel in de analyse meegenomen. Met behulp van regressie 
analyses en door extrapolatie van de regressielijnen werd een idee verkregen over de mate 
van progressie en het moment waarop achteruitgang van gezichtsvermogen of beperking van 
het gezichtsveld aanving. Nachtblmdheid, aanvang van visusvermindenng en achteruitgang 
van het gezichtsveld traden bij type ΙΒ gemiddeld 6-8 jaar eerder op dan bij USH2A. 
Berekend kon worden dat in 10 jaar tijd, het gezichtsvermogen voor beide typen gemiddeld 
met 0.2 zou dalen. Een beperking van het bestaande gezichtsveld met de helft zou bij beide 
typen ongeveer 13 jaar duren De waargenomen verschillen tussen USH ΙΒ en USH2A 
lijken met te berusten op het feit dat de retinale pigmentdegeneratie degeneratie bij USH ΙΒ 
ernstiger verloopt dan bij USH2A maar wel op het feit dat de pigmentdegeneratie zich bij 
USH Ι Β eerder openbaart. Deze informatie is van belang bij het informeren, adviseren en 
begeleiden van mensen met het syndroom van Usher type ΙΒ en 2A. 
Fundoscopisch onderzoek werd in het kader van een eerder onderzoek naar Usher type 2A 
bij 24 familiaire gevallen van USH2A verricht. Dertien geïsoleerde gevallen met Usher type II 
werden nog in de analyse opgenomen Binnen families bleek sprake te zijn van opmerkelijke 
vanatie in gezichtsvermogen. Alle patiënten werden fundoscopisch onderzocht en 
fundusbeeiden werden geclassificeerd Type A fundus beelden werden gekenmerkt door 
beenbalkjes in alle kwadranten van de retina met centraal een vernauwing van de artenolen 
en aanwezigheid van een bleke papil Alle andere fundus beelden werden geclassificeerd als 
type Β Het aandeel type A fundus beelden nam toe met het vorderen van de leeftijd. 
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Conclusies 
Resultaten beschreven in bovenstaande hoofdstukken hebben geleid tot de volgende 
conclusies. 
Individuele detectie van obligate dragers van het syndroom van Usher type I door middel 
van toon audiometrie en Audioscan audiometne is weinig specifiek en daarom met klinisch 
toepasbaar. 
Bi) het syndroom van Usher kan een direct verband tussen een klinisch type en de daarbij 
waargenomen histopathologic van het binnenoor met worden aangetoond. Histopathologie 
van de cochlea bij het syndroom van Usher laat een nagenoeg uniform beeld zien ongeacht 
het klinisch type. Indien histopathologische afwijkingen op vestibulair mvo worden 
waargenomen lijkt dit vaker het geval bij Usher type I patiënten dan bij Usher type II 
patiënten. 
De histopathologie van het binnenoor bij een USHI D/F patiënt toont het beeld van een 
cochleo-sacculaire degeneratie 
Onderzoek van de cochleaire kernen van 2 Usher type I patiënten, die sedert hun geboorte 
geluidsgedepnveerd waren, toonde een lichte afname m de gemiddelde diameter van de 
cellen van de ventrale cochleaire kern. Er werden geen duidelijke tekenen van degeneratie 
van de cochleaire kernen waargenomen. 
Audiologisch onderzoek laat bij USH ΙΒ patiënten in de minderheid van de gevallen een 
restgehoor zien in de lage en midden frequencies. Gehoorveriies bij USH ΙΒ lijkt 
onafhankelijk van de leeftijd. 
Vergelijkend audiologisch onderzoek toont dat USH ΙΒ en USH2A audiometnsch goed te 
onderscheiden zijn bij de respectievelijke frequenties 0 25, 0.5, I kHZ op leeftijden jonger 
dan 40 jaar Overlap in gehoorsverlies tussen USH ΙΒ and USH2A komt voor bij de hogere 
frequenties en op hogere leeftijd 
Gehoorsverlies bij USH2A patiënten in deze studie vertoont progressie welke met uitsluitend 
door presbyacusis verklaard wordt 
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Vergelijkend oogheelkundig onderzoek tussen USH ΙΒ en USH2A maakt duidelijk dat retinitis 
pigmentosa bij USH ΙΒ met ernstiger van aard is dan retinitis pigmentosa bij USH2A maar 
enkel eerder lijkt aan te vangen (6-8 jaar eerder). 
Fundoscopische bevindingen bij USH2A patiënten worden gekenmerkt door een grote 
variatie 
De Toekomst. 
Door recente genetisch klassificaties van ziektebeelden dreigen oude klinische en 
histologische beschnjvmgen en indelingen hun waarde te verliezen. De vordenngen die 
momenteel op een gebied van de genetica en de erfelijke slechthorendheid gemaakt 
worden, werpen inderdaad een heel nieuw licht op eerdere indelingen. Tussen klinisch 
verschillende aandoeningen blijken genetische overeenkomsten te bestaan terwijl daarnaast 
klinisch verwante aandoening, genetisch van elkaar kunnen verschillen Voor het uiteindelijk 
achterhalen van de diverse pathofysiologische mechanismen die aan vormen van erfelijke 
slechthorendheid ten grondslag liggen is het van belang telkens een relatie te leggen tussen 
de nieuwe kennis en de oude inzichten. In dit kader is genetisch en blijft klinisch onderzoek 
naar het syndroom van Usher van essentieel belang. Op deze manier is kennis omtrent het 
Usher syndroom toegenomen en zal deze nog verder moeten toenemen. 
Het is duidelijk geworden dat 9 verschillende genetisch subtypen van he Usher syndroom 
bestaan. De genen verantwoordelijk voor de twee meest voorkomende typen van het 
Usher syndroom, USH ΙΒ en USH2A, zijn inmiddels geïdentificeerd. In de zeer nabije 
toekomst is het mogelijk door middel van gendiagnostiek binnen aangedane families te 
bepalen wie drager is van het Usher gen. De kwaliteit van erfelijkheidsadvisenng zal hierdoor 
toenemen. Tevens zal het mogelijk zijn om met behulp van deze gendiagnostiek het 
syndroom van Usher al op babyleeftijd met zekerheid te diagnostiseren. Tot op heden was 
dit op zeer jonge leeftijd nog steeds moeilijk. Het vroeg kunnen stellen van de diagnose helpt 
verandenngen in de ontwikkeling te verklaren en stelt ouders en hulpverleners in staat om 
het kind met Usher een optimale begeleiding te geven. 
Natuurlijk hopen WIJ dat verder onderzoek naar de klinische verschijningsvormen van het 
syndroom van Usher en de genetica, de kennis omtrent de diverse pathofyiologische 
mechanismen welke aan het syndroom ten grondslag liggen, doet toenemen. Zo zal 
uiteindelijk enige vorm van behandeling van het Usher syndroom in de toekomst mogelijk 
worden. 
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1 Mutaties in het humane gen, dat codeert voor myosme Vila, 
zijn verantwoordelijk voor het ontstaan van het syndroom van 
Usher type IB (Weil D et al, Nature 1995, 374 60-61) 
2 Hoewel het histopathologisch beeld van de cochlea bij de 
klinische subtypen van het syndroom van Usher zich kenmerkt 
door uniformiteit, vertoont het gehoorverlies van deze subtypen 
grote variatie (dit proefschrift) 
3 Het syndroom van Usher type ΙΒ en 2A kan bij personen 
jonger dan 40 jaar onderscheiden worden op grond van het 
audiogram en wel in het frequentiebereik onder 1000 Hz 
(dit proefschrift) 
4 Het gehoorverlies bij mensen met het syndroom van Usher type 
2A toont een progressie welke met alleen door presbyacusis 
verklaard kan worden (dit proefschrift) 
5 Het klinisch beloop van retinitis pigmentosa bij mensen met het 
syndroom van Usher type ΙΒ lijkt ernstiger dan bij personen 
met Usher syndroom type 2A, omdat het gemiddeld 6 tot 8 
jaar eerder aanvangt (dit proefschrift) 
6 DNFBI is opvallend vaak de oorzaak van een onverklaarde 
perceptieve slechthorendheid bij jonge kind Mutatieanalyse 
van connexme 26 is daarom een belangrijk nieuw diagnosticum 
voor de klinische praktijk 
(Mueller R et al, IntJ Ped Otorhmolaryngol 1999, 50 3-13) 
7 Het feit dat by de ziekte van Kimura een perifere eosinofilie in 
combinatie met een verhoogd IgE gevonden wordt, doet 
vermoeden dat er sprake is van een inflammatoire reactie tegen 
een onbekend antigeen 
(WagenaarM etal.NTvG 1998, 142 532-535) 
8 Door plaatsing van de floating mass transducer aan de incus als 
onderdeel van het deels implanteerbare hoortoestel, de Vibrant 
Soundbridge, wordt de incus zwaarder Hierdoor verbetert de 
gemeten beengeleidmgsdrempel in het toonaudiogram en 
ontstaat er een pseudo luchtgeleidmgscomponent 
(Snik A et al, Clin Otolaryngol 1998, 23 414-419) 
9 Het resultaat van de behandeling van een oncologische patient 
dient in hoge mate te worden afgemeten aan de kwaliteit van 
leven en met alleen aan de overlevmgsduur 
10 Een patient is meer gebaat bij een arts met een hoog EQ dan bij 
één met uitsluitend een hoog IQ 
I I A man falls in love through his eyes, a woman through her ears 
(Wood row Wyatt) 
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